-
1
-
-
0035944828
-
Relation between depression after coronary artery bypass surgery and 12-month outcome: A prospective study
-
Connerney I, Shapiro PA, McLaughlin JS, Bagiella E, Sloan RP. Relation between depression after coronary artery bypass surgery and 12-month outcome: a prospective study. Lancet. 2001;358:1766-1771.
-
(2001)
Lancet
, vol.358
, pp. 1766-1771
-
-
Connerney, I.1
Shapiro, P.A.2
McLaughlin, J.S.3
Bagiella, E.4
Sloan, R.P.5
-
3
-
-
9244225620
-
Prognostic association of depression following myocardial infarction with mortality and cardiovascular events: A meta-analysis
-
van Melle JP, de Jonge P, Spijkerman TA, et al. Prognostic association of depression following myocardial infarction with mortality and cardiovascular events: a meta-analysis. Psychosom Med. 2004;66:814-822.
-
(2004)
Psychosom Med
, vol.66
, pp. 814-822
-
-
van Melle, J.P.1
de Jonge, P.2
Spijkerman, T.A.3
-
4
-
-
0029801617
-
Is anxiety early after myocardial infarction associated with subsequent ischemic and arrhythmic events?
-
Moser DK, Dracup K. Is anxiety early after myocardial infarction associated with subsequent ischemic and arrhythmic events? Psychosom Med. 1996;58:395-401.
-
(1996)
Psychosom Med
, vol.58
, pp. 395-401
-
-
Moser, D.K.1
Dracup, K.2
-
5
-
-
0029366801
-
The impact of negative emotions on prognosis following myocardial infarction: Is it more than depression?
-
Frasure-Smith N, Lesperance F, Talajic M. The impact of negative emotions on prognosis following myocardial infarction: is it more than depression? Health Psychol. 1995;14:388-398.
-
(1995)
Health Psychol
, vol.14
, pp. 388-398
-
-
Frasure-Smith, N.1
Lesperance, F.2
Talajic, M.3
-
6
-
-
28444493009
-
Delirium in the postoperative cardiac patient: A review
-
Sockalingam S, Parekh N, Bogoch II, et al. Delirium in the postoperative cardiac patient: a review. J Card Surg. 2005;20:560-567.
-
(2005)
J Card Surg
, vol.20
, pp. 560-567
-
-
Sockalingam, S.1
Parekh, N.2
Bogoch II3
-
7
-
-
0025305110
-
Propranolol and depression: Evidence from the antihypertensive trials
-
Patten SB. Propranolol and depression: evidence from the antihypertensive trials. Can J Psychiatry. 1990;35:257-259.
-
(1990)
Can J Psychiatry
, vol.35
, pp. 257-259
-
-
Patten, S.B.1
-
8
-
-
0021018314
-
Propranolol-induced depression: Mechanism and management
-
Oppenheim G. Propranolol-induced depression: mechanism and management. Aust N Z J Psychiatry. 1983;17:400-402.
-
(1983)
Aust N Z J Psychiatry
, vol.17
, pp. 400-402
-
-
Oppenheim, G.1
-
9
-
-
0019967022
-
Substitution of atenolol for propranolol in a case of propranolol-related depression
-
McNeil GN, Shaw PK, Dock DS. Substitution of atenolol for propranolol in a case of propranolol-related depression. Am J Psychiatry. 1982;139:1187-1188.
-
(1982)
Am J Psychiatry
, vol.139
, pp. 1187-1188
-
-
McNeil, G.N.1
Shaw, P.K.2
Dock, D.S.3
-
10
-
-
0021917486
-
Propranolol and depression revisited: Three cases and a review
-
Pollack MH, Rosenbaum JF, Cassem NH. Propranolol and depression revisited: three cases and a review. J Nerv Ment Dis. 1985;173:118-119.
-
(1985)
J Nerv Ment Dis
, vol.173
, pp. 118-119
-
-
Pollack, M.H.1
Rosenbaum, J.F.2
Cassem, N.H.3
-
11
-
-
84965269930
-
Propanolol-induced depression
-
Fitzgerald JD. Propanolol-induced depression. BMJ. 1967;2:372-373.
-
(1967)
BMJ
, vol.2
, pp. 372-373
-
-
Fitzgerald, J.D.1
-
12
-
-
0025027043
-
Increased prescribing of antidepressants subsequent to beta-blocker ther apy
-
Thiessen BQ, Wallace SM, Blackburn JL, Wilson TW, Bergman U. Increased prescribing of antidepressants subsequent to beta-blocker ther apy. Arch Intern Med. 1990;150:2286-2290.
-
(1990)
Arch Intern Med
, vol.150
, pp. 2286-2290
-
-
Thiessen, B.Q.1
Wallace, S.M.2
Blackburn, J.L.3
Wilson, T.W.4
Bergman, U.5
-
13
-
-
0029821351
-
Evidence of depression provoked by cardiovascular medication: A prescription sequence symmetry analysis
-
Hallas J. Evidence of depression provoked by cardiovascular medication: a prescription sequence symmetry analysis. Epidemiology. 1996;7:478-484.
-
(1996)
Epidemiology
, vol.7
, pp. 478-484
-
-
Hallas, J.1
-
14
-
-
0025350611
-
Antihypertensive therapy and quality of life: A comparison of atenolol, captopril, enalapril and propranolol
-
Steiner SS, Friedhoff AJ, Wilson BL, Wecker JR, Santo JP. Antihypertensive therapy and quality of life: a comparison of atenolol, captopril, enalapril and propranolol. J Hum Hypertens. 1990;4:217-225.
-
(1990)
J Hum Hypertens
, vol.4
, pp. 217-225
-
-
Steiner, S.S.1
Friedhoff, A.J.2
Wilson, B.L.3
Wecker, J.R.4
Santo, J.P.5
-
15
-
-
0342858928
-
The effects of propranolol on cognitive function and quality of life: A randomized trial among patients with diastolic hypertension (no increase in depression at 12 months, 312 patients)
-
Perez-Stable EJ, Halliday R, Gardiner PS, et al. The effects of propranolol on cognitive function and quality of life: a randomized trial among patients with diastolic hypertension (no increase in depression at 12 months, 312 patients). Am J Med. 2000;108:359-365.
-
(2000)
Am J Med
, vol.108
, pp. 359-365
-
-
Perez-Stable, E.J.1
Halliday, R.2
Gardiner, P.S.3
-
16
-
-
0026534403
-
Beta-blockers and depression. Evidence against an association
-
Bright RA, Everitt DE. Beta-blockers and depression. Evidence against an association. JAMA. 1992;267:1783-1787.
-
(1992)
JAMA
, vol.267
, pp. 1783-1787
-
-
Bright, R.A.1
Everitt, D.E.2
-
17
-
-
0021436759
-
Propranolol and depression: A reevaluation based on a pilot clinical trial
-
Stoudemire A, Brown JT, Harris RT, et al. Propranolol and depression: a reevaluation based on a pilot clinical trial. Psychiatr Med. 1984;2:211-218.
-
(1984)
Psychiatr Med
, vol.2
, pp. 211-218
-
-
Stoudemire, A.1
Brown, J.T.2
Harris, R.T.3
-
18
-
-
0023614091
-
Prevalence of major depressive disorder in patients receiving beta-blocker therapy versus other medications
-
Carney RM, Rich MW, teVelde A, Saini J, Clark K, Freedland KE. Prevalence of major depressive disorder in patients receiving beta-blocker therapy versus other medications. Am J Med. 1987;83:223-226.
-
(1987)
Am J Med
, vol.83
, pp. 223-226
-
-
Carney, R.M.1
Rich, M.W.2
teVelde, A.3
Saini, J.4
Clark, K.5
Freedland, K.E.6
-
20
-
-
0030197610
-
The incidence of depression in new users of beta-blockers and selected antihypertensives
-
Gerstman BB, Jolson HM, Bauer M, Cho P, Livingston JM, Platt R. The incidence of depression in new users of beta-blockers and selected antihypertensives. J Clin Epidemiol. 1996;49:809-815.
-
(1996)
J Clin Epidemiol
, vol.49
, pp. 809-815
-
-
Gerstman, B.B.1
Jolson, H.M.2
Bauer, M.3
Cho, P.4
Livingston, J.M.5
Platt, R.6
-
21
-
-
0037125378
-
Beta-blocker therapy and symptoms of depression, fatigue, and sexual dysfunction
-
Ko DT, Hebert PR, Coffey CS, Sedrakyan A, Curtis JP, Krumholz HM. Beta-blocker therapy and symptoms of depression, fatigue, and sexual dysfunction. JAMA. 2002;288:351-357.
-
(2002)
JAMA
, vol.288
, pp. 351-357
-
-
Ko, D.T.1
Hebert, P.R.2
Coffey, C.S.3
Sedrakyan, A.4
Curtis, J.P.5
Krumholz, H.M.6
-
22
-
-
0024523868
-
Neuropsychological side effects of beta-blockers
-
Dimsdale JE, Newton RP, Joist T. Neuropsychological side effects of beta-blockers. Arch Intern Med. 1989;149:514-525.
-
(1989)
Arch Intern Med
, vol.149
, pp. 514-525
-
-
Dimsdale, J.E.1
Newton, R.P.2
Joist, T.3
-
23
-
-
0020416916
-
Psychiatric side effects of antihypertensive drugs other than reserpine
-
Paykel ES, Fleminger R, Watson JP. Psychiatric side effects of antihypertensive drugs other than reserpine. J Clin Psychopharmacol. 1982;2:14-39.
-
(1982)
J Clin Psychopharmacol
, vol.2
, pp. 14-39
-
-
Paykel, E.S.1
Fleminger, R.2
Watson, J.P.3
-
24
-
-
34247183871
-
atenolol) prescribing information
-
Wilmington, Del: AstraZeneca;
-
Tenormin (atenolol) prescribing information. Wilmington, Del: AstraZeneca; 2005.
-
(2005)
-
-
Tenormin1
-
25
-
-
0026576464
-
Cognitive effects of beta-blockers
-
Dimsdale JE, Newton RP. Cognitive effects of beta-blockers. J Psychosom Res. 1992;36:229-236.
-
(1992)
J Psychosom Res
, vol.36
, pp. 229-236
-
-
Dimsdale, J.E.1
Newton, R.P.2
-
26
-
-
0024523868
-
Neuropsychological side effects of beta-blockers
-
Dimsdale JE, Newton RP, Joist T. Neuropsychological side effects of beta-blockers. Arch Intern Med. 1989;149:514-525.
-
(1989)
Arch Intern Med
, vol.149
, pp. 514-525
-
-
Dimsdale, J.E.1
Newton, R.P.2
Joist, T.3
-
27
-
-
0029103414
-
Toxic psychosis: An unusual presentation of propranolol intoxication
-
Love JN, Handler JA. Toxic psychosis: an unusual presentation of propranolol intoxication. Am J Emerg Med. 1995;13:536-537.
-
(1995)
Am J Emerg Med
, vol.13
, pp. 536-537
-
-
Love, J.N.1
Handler, J.A.2
-
29
-
-
0021964165
-
Propranolol-induced depression and psychosis
-
Parker WA. Propranolol-induced depression and psychosis. Clin Pharmacol. 1985;4:214-218.
-
(1985)
Clin Pharmacol
, vol.4
, pp. 214-218
-
-
Parker, W.A.1
-
32
-
-
33748433966
-
Clinical practice. Social anxiety disorder
-
Schneier FR. Clinical practice. Social anxiety disorder. N Engl J Med. 2006;355:1029-1036.
-
(2006)
N Engl J Med
, vol.355
, pp. 1029-1036
-
-
Schneier, F.R.1
-
33
-
-
0037109802
-
What to do when SSRIs fail: Eight strategies for optimizing treatment of panic disorder
-
Zamorski MA, Albucher RC. What to do when SSRIs fail: eight strategies for optimizing treatment of panic disorder. Am Fam Physician. 2002;66:1477-1484.
-
(2002)
Am Fam Physician
, vol.66
, pp. 1477-1484
-
-
Zamorski, M.A.1
Albucher, R.C.2
-
34
-
-
0033829587
-
Pindolol augmentation in patients with treatment-resistant panic disorder: A double-blind, placebo-controlled trial
-
Hirschmann S, Dannon PN, Iancu I, Dolberg OT, Zohar J, Grunhaus L. Pindolol augmentation in patients with treatment-resistant panic disorder: A double-blind, placebo-controlled trial. J Clin Psychopharmacol. 2000;20:556-559.
-
(2000)
J Clin Psychopharmacol
, vol.20
, pp. 556-559
-
-
Hirschmann, S.1
Dannon, P.N.2
Iancu, I.3
Dolberg, O.T.4
Zohar, J.5
Grunhaus, L.6
-
35
-
-
0034004169
-
Pindolol augmentation in treatment-resistant obsessive compulsive disorder: A double-blind placebo controlled trial
-
Dannon PN, Sasson Y, Hirschmann S, Iancu I, Grunhaus LJ, Zohar J. Pindolol augmentation in treatment-resistant obsessive compulsive disorder: a double-blind placebo controlled trial. Eur Neuropsychopharmacol. 2000;10:165-169.
-
(2000)
Eur Neuropsychopharmacol
, vol.10
, pp. 165-169
-
-
Dannon, P.N.1
Sasson, Y.2
Hirschmann, S.3
Iancu, I.4
Grunhaus, L.J.5
Zohar, J.6
-
36
-
-
0142188601
-
-
Vaiva G, Ducrocq F, Jezequel K, et al. Immediate treatment with propranolol decreases posttraumatic stress disorder two months after trauma. Biol Psychiatry. 2003;54:947-949. Erratum in: Biol Psychiatry. 2003;54:1471.
-
Vaiva G, Ducrocq F, Jezequel K, et al. Immediate treatment with propranolol decreases posttraumatic stress disorder two months after trauma. Biol Psychiatry. 2003;54:947-949. Erratum in: Biol Psychiatry. 2003;54:1471.
-
-
-
-
37
-
-
0037081437
-
Pilot study of secondary prevention of posttraumatic stress disorder with propranolol
-
Pitman RK, Sanders KM, Zusman RM, et al. Pilot study of secondary prevention of posttraumatic stress disorder with propranolol. Biol Psychiatry. 2002;51:189-192.
-
(2002)
Biol Psychiatry
, vol.51
, pp. 189-192
-
-
Pitman, R.K.1
Sanders, K.M.2
Zusman, R.M.3
-
38
-
-
0037268429
-
Pharmacological management for agitation and aggression in people with acquired brain injury
-
CD003299
-
Fleminger S, Greenwood RJ, Oliver DL. Pharmacological management for agitation and aggression in people with acquired brain injury. Cochrane Database Syst Rev. 2003;1:CD003299.
-
(2003)
Cochrane Database Syst Rev
, pp. 1
-
-
Fleminger, S.1
Greenwood, R.J.2
Oliver, D.L.3
-
39
-
-
0028928734
-
Beta-blockers and the treatment of aggression
-
Haspel T. Beta-blockers and the treatment of aggression. Harv Rev Psychiatry. 1995;2:274-281.
-
(1995)
Harv Rev Psychiatry
, vol.2
, pp. 274-281
-
-
Haspel, T.1
-
40
-
-
0031005348
-
Psychopharmacologic treatment of pathologic aggression
-
Fava M. Psychopharmacologic treatment of pathologic aggression. Psychiatr Clin North Am. 1997;20:427-451.
-
(1997)
Psychiatr Clin North Am
, vol.20
, pp. 427-451
-
-
Fava, M.1
-
41
-
-
16844373488
-
Propranolol for disruptive behaviors in nursing home residents with probable or possible Alzheimer disease: A placebo-controlled study
-
Peskind ER, Tsuang DW, Bonner LT, et al. Propranolol for disruptive behaviors in nursing home residents with probable or possible Alzheimer disease: a placebo-controlled study. Alzheimer Dis Assoc Disord. 2005;19:23-28.
-
(2005)
Alzheimer Dis Assoc Disord
, vol.19
, pp. 23-28
-
-
Peskind, E.R.1
Tsuang, D.W.2
Bonner, L.T.3
-
42
-
-
14044274779
-
Neuroleptic-induced movement disorders: An overview
-
Sachdev PS. Neuroleptic-induced movement disorders: an overview. Psychiatr Clin North Am. 2005;28:255-274.
-
(2005)
Psychiatr Clin North Am
, vol.28
, pp. 255-274
-
-
Sachdev, P.S.1
-
43
-
-
0024591499
-
The efficacy of atenolol in the outpatient management of the alcohol withdrawal syndrome. Results of a randomized clinical trial
-
Horwitz RI, Gottlieb LD, Kraus ML. The efficacy of atenolol in the outpatient management of the alcohol withdrawal syndrome. Results of a randomized clinical trial. Arch Intern Med. 1989;149:1089-1093.
-
(1989)
Arch Intern Med
, vol.149
, pp. 1089-1093
-
-
Horwitz, R.I.1
Gottlieb, L.D.2
Kraus, M.L.3
-
44
-
-
0022346653
-
Randomized clinical trial of atenolol in patients with alcohol withdrawal
-
Kraus ML, Gottlieb LD, Horwitz RI, Anscher M. Randomized clinical trial of atenolol in patients with alcohol withdrawal. N Engl J Med. 1985;313:905-909.
-
(1985)
N Engl J Med
, vol.313
, pp. 905-909
-
-
Kraus, M.L.1
Gottlieb, L.D.2
Horwitz, R.I.3
Anscher, M.4
-
45
-
-
1542404781
-
Effectiveness of pindolol plus serotonin uptake inhibitors in depression: A meta-analysis of early and late outcomes from randomised controlled trials
-
Ballesteros J, Callado LF. Effectiveness of pindolol plus serotonin uptake inhibitors in depression: a meta-analysis of early and late outcomes from randomised controlled trials. J Affect Disord. 2004;79:137-147.
-
(2004)
J Affect Disord
, vol.79
, pp. 137-147
-
-
Ballesteros, J.1
Callado, L.F.2
-
46
-
-
0024549875
-
Differentiation of angiotensin-converting enzyme (ACE) inhibitors by their selective inhibition of ACE in physiologically important target organs
-
Cushman DW, Wang FL, Fung WC, Harvey CM, DeForrest JM. Differentiation of angiotensin-converting enzyme (ACE) inhibitors by their selective inhibition of ACE in physiologically important target organs. Am J Hypertens. 1989;2:294-306.
-
(1989)
Am J Hypertens
, vol.2
, pp. 294-306
-
-
Cushman, D.W.1
Wang, F.L.2
Fung, W.C.3
Harvey, C.M.4
DeForrest, J.M.5
-
47
-
-
0037344546
-
Neuropsychiatric effects of cardiovascular drug therapy
-
Keller S, Frishman WH. Neuropsychiatric effects of cardiovascular drug therapy. Cardiol Rev. 2003;11:73-93.
-
(2003)
Cardiol Rev
, vol.11
, pp. 73-93
-
-
Keller, S.1
Frishman, W.H.2
-
49
-
-
0024564810
-
Captopril treatment of major depression with serial measurements of blood Cortisol concentrations
-
Germain L, Chouinard G. Captopril treatment of major depression with serial measurements of blood Cortisol concentrations. Biol Psychiatry. 1989;25:489-493.
-
(1989)
Biol Psychiatry
, vol.25
, pp. 489-493
-
-
Germain, L.1
Chouinard, G.2
-
50
-
-
0023847794
-
Treatment of recurrent unipolar major depression with captopril
-
Germain L, Chouinard G. Treatment of recurrent unipolar major depression with captopril. Biol Psychiatry. 1988;23:637-641.
-
(1988)
Biol Psychiatry
, vol.23
, pp. 637-641
-
-
Germain, L.1
Chouinard, G.2
-
51
-
-
0022655123
-
The effects of antihypertensive therapy on the quality of life
-
Croog SH, Levine S, Testa MA, et al. The effects of antihypertensive therapy on the quality of life. N Engl J Med. 1986;314:1657-1664.
-
(1986)
N Engl J Med
, vol.314
, pp. 1657-1664
-
-
Croog, S.H.1
Levine, S.2
Testa, M.A.3
-
53
-
-
0025891553
-
Manic symptoms associated with the use of captopril
-
Patten SB, Brager N, Sanders S. Manic symptoms associated with the use of captopril. Can J Psychiatry. 1991;36:314-315.
-
(1991)
Can J Psychiatry
, vol.36
, pp. 314-315
-
-
Patten, S.B.1
Brager, N.2
Sanders, S.3
-
54
-
-
0021869512
-
Bipolar affective symptoms associated with use of captopril and abrupt withdrawal of pargyline and propranolol
-
McMahon T. Bipolar affective symptoms associated with use of captopril and abrupt withdrawal of pargyline and propranolol. Am J Psychiatry. 1985;142:759-760.
-
(1985)
Am J Psychiatry
, vol.142
, pp. 759-760
-
-
McMahon, T.1
-
55
-
-
0029117955
-
Mania secondary to lisinopril therapy
-
Skop BP, Masterson BJ. Mania secondary to lisinopril therapy. Psychosomatics. 1995;36:508-509.
-
(1995)
Psychosomatics
, vol.36
, pp. 508-509
-
-
Skop, B.P.1
Masterson, B.J.2
-
56
-
-
0025751707
-
The use of captopril in treatment-resistant depression: An open trial
-
Vuckovic A, Cohen BM, Zubenko GS. The use of captopril in treatment-resistant depression: an open trial. J Clin Psychopharmacol. 1991;11:395-396.
-
(1991)
J Clin Psychopharmacol
, vol.11
, pp. 395-396
-
-
Vuckovic, A.1
Cohen, B.M.2
Zubenko, G.S.3
-
58
-
-
0025758867
-
Enalapril-induced acute psychosis
-
Ahmad S. Enalapril-induced acute psychosis. DICP. 1991;25:558-559.
-
(1991)
DICP
, vol.25
, pp. 558-559
-
-
Ahmad, S.1
-
59
-
-
0000989030
-
Reversal of captopril-induced psychosis with naloxone
-
Gillman MA, Sandyk R. Reversal of captopril-induced psychosis with naloxone. Am J Psychiatry. 1985;142:270.
-
(1985)
Am J Psychiatry
, vol.142
, pp. 270
-
-
Gillman, M.A.1
Sandyk, R.2
-
60
-
-
0032943339
-
Effects of captopril and enalapril on electroencephalogram and cognitive performance in healthy volunteers
-
Ebert U, Kirch W. Effects of captopril and enalapril on electroencephalogram and cognitive performance in healthy volunteers. Eur J Clin Pharmacol. 1999;55:255-257.
-
(1999)
Eur J Clin Pharmacol
, vol.55
, pp. 255-257
-
-
Ebert, U.1
Kirch, W.2
-
61
-
-
0025184176
-
Central effects of the angiotensin-converting enzyme inhibitor, captopril. I. Performance and subjective assessments of mood
-
Currie D, Lewis RV, McDevitt DG, Nicholson AN, Wright NA. Central effects of the angiotensin-converting enzyme inhibitor, captopril. I. Performance and subjective assessments of mood. Br J Clin Pharmacol. 1990;30:527-536.
-
(1990)
Br J Clin Pharmacol
, vol.30
, pp. 527-536
-
-
Currie, D.1
Lewis, R.V.2
McDevitt, D.G.3
Nicholson, A.N.4
Wright, N.A.5
-
62
-
-
0027327689
-
A pilot clinical trial of the angiotensin-converting enzyme inhibitor ceranapril in Alzheimer disease
-
Sudilovsky A, Cutler NR, Sramek JJ, et al. A pilot clinical trial of the angiotensin-converting enzyme inhibitor ceranapril in Alzheimer disease. Alzheimer Dis Assoc Disord. 1993;7:105-111.
-
(1993)
Alzheimer Dis Assoc Disord
, vol.7
, pp. 105-111
-
-
Sudilovsky, A.1
Cutler, N.R.2
Sramek, J.J.3
-
63
-
-
34247243802
-
-
Capoten (captopril) prescribing information. Princeton, NJ: Brisol-Myers Squibb; 1996.
-
Capoten (captopril) prescribing information. Princeton, NJ: Brisol-Myers Squibb; 1996.
-
-
-
-
64
-
-
34247190316
-
lisinopril) prescribing information
-
Wilmington, Del; McNeil Consumer & Specialty Pharmaceuticals;
-
Zestril (lisinopril) prescribing information. Wilmington, Del; McNeil Consumer & Specialty Pharmaceuticals; 2002.
-
(2002)
-
-
Zestril1
-
65
-
-
0030750293
-
Valsartan. A review of its pharmacology and therapeutic use in essential hypertension
-
Review
-
Markham A, Goa KL. Valsartan. A review of its pharmacology and therapeutic use in essential hypertension. Drugs. 1997;54:299-311. Review.
-
(1997)
Drugs
, vol.54
, pp. 299-311
-
-
Markham, A.1
Goa, K.L.2
-
66
-
-
0030798211
-
Clinical safety and tolerability of losartan
-
Weber M. Clinical safety and tolerability of losartan. Clin Ther. 1997;19:604-616.
-
(1997)
Clin Ther
, vol.19
, pp. 604-616
-
-
Weber, M.1
-
67
-
-
2342577439
-
Irbesartan: A review of its use in hypertension and in the management of diabetic nephropathy
-
Croom KF, Curran MP, Goa KL, Perry CM. Irbesartan: a review of its use in hypertension and in the management of diabetic nephropathy. Drugs. 2004;64:999-1028.
-
(2004)
Drugs
, vol.64
, pp. 999-1028
-
-
Croom, K.F.1
Curran, M.P.2
Goa, K.L.3
Perry, C.M.4
-
68
-
-
0344303556
-
Episodes of depression with attempted suicide after taking valsartan with hydrochlorothiazide [in German]
-
Ullrich H, Passenberg P, Agelink MW. Episodes of depression with attempted suicide after taking valsartan with hydrochlorothiazide [in German]. Dtsch Med Wochenschr. 2003;128:2534-2536.
-
(2003)
Dtsch Med Wochenschr
, vol.128
, pp. 2534-2536
-
-
Ullrich, H.1
Passenberg, P.2
Agelink, M.W.3
-
69
-
-
0029775599
-
Losartan and reversible psychosis
-
Ahmad S. Losartan and reversible psychosis. Cardiology. 1996;87:569-570.
-
(1996)
Cardiology
, vol.87
, pp. 569-570
-
-
Ahmad, S.1
-
70
-
-
0032709918
-
Comparison of losartan and hydrochlorothiazide on cognitive function and quality of life in hypertensive patients
-
Tedesco MA, Ratti G, Mennella S, et al. Comparison of losartan and hydrochlorothiazide on cognitive function and quality of life in hypertensive patients. Am J Hypertens. 1999;12:1130-1134.
-
(1999)
Am J Hypertens
, vol.12
, pp. 1130-1134
-
-
Tedesco, M.A.1
Ratti, G.2
Mennella, S.3
-
71
-
-
0020634830
-
Update on calcium-channel blocking agents
-
Talbert RL, Bussey HI. Update on calcium-channel blocking agents. Clin Pharm. 1983;2:403-416.
-
(1983)
Clin Pharm
, vol.2
, pp. 403-416
-
-
Talbert, R.L.1
Bussey, H.I.2
-
72
-
-
34247251550
-
amlodipine ) prescribing information
-
New York, NY: Pfizer Labs;
-
Norvasc (amlodipine ) prescribing information. New York, NY: Pfizer Labs; 2003.
-
(2003)
-
-
Norvasc1
-
73
-
-
34247234698
-
verapamil) prescribing information
-
Chicago, III: GD Searle LLC, a subsidiary of Pharmacia Corporation
-
Calan (verapamil) prescribing information. Chicago, III: GD Searle LLC, a subsidiary of Pharmacia Corporation, 2003.
-
(2003)
-
-
Calan1
-
75
-
-
0023912516
-
Organic psychosis caused by diltiazem
-
Busche CJ. Organic psychosis caused by diltiazem. J R Soc Med. 1988;81:296-297.
-
(1988)
J R Soc Med
, vol.81
, pp. 296-297
-
-
Busche, C.J.1
-
76
-
-
0027080401
-
The calcium channel antagonist nifedipine causes confusion when used to treat opiate withdrawal in morphine-dependent patients
-
Silverstone PH, Attenburrow MJ, Robson P. The calcium channel antagonist nifedipine causes confusion when used to treat opiate withdrawal in morphine-dependent patients. Int Clin Psychopharmacol. 1992;7:87-90.
-
(1992)
Int Clin Psychopharmacol
, vol.7
, pp. 87-90
-
-
Silverstone, P.H.1
Attenburrow, M.J.2
Robson, P.3
-
80
-
-
0021736522
-
Antimanic effects of verapamil
-
Giannini AJ, Houser WL, Loiselle RH, Giannini MC, Price WA. Antimanic effects of verapamil. Am J Psychiatry. 1984;141:1602-1603.
-
(1984)
Am J Psychiatry
, vol.141
, pp. 1602-1603
-
-
Giannini, A.J.1
Houser, W.L.2
Loiselle, R.H.3
Giannini, M.C.4
Price, W.A.5
-
81
-
-
0024493361
-
Verapamil in affective disorders: A controlled, double-blind study
-
Hoschl C, Kozeny J. Verapamil in affective disorders: a controlled, double-blind study. Biol Psychiatry. 1989;25:128-140.
-
(1989)
Biol Psychiatry
, vol.25
, pp. 128-140
-
-
Hoschl, C.1
Kozeny, J.2
-
83
-
-
0029801080
-
Superiority of lithium over verapamil in mania: A randomized, controlled, single-blind trial
-
Walton SA, Berk M, Brook S. Superiority of lithium over verapamil in mania: a randomized, controlled, single-blind trial. J Clin Psychiatry. 1996;57:543-546.
-
(1996)
J Clin Psychiatry
, vol.57
, pp. 543-546
-
-
Walton, S.A.1
Berk, M.2
Brook, S.3
-
84
-
-
0031800861
-
Verapamil for the treatment of acute mania: A double-blind, placebo-controlled trial
-
Janicak PG, Sharma RP, Pandey G, Davis JM. Verapamil for the treatment of acute mania: a double-blind, placebo-controlled trial. Am J Psychiatry. 1998;155:972-973.
-
(1998)
Am J Psychiatry
, vol.155
, pp. 972-973
-
-
Janicak, P.G.1
Sharma, R.P.2
Pandey, G.3
Davis, J.M.4
-
85
-
-
0036569898
-
Verapamil treatment for women with bipolar disorder
-
Wisner KL, Peindl KS, Perel JM, Hanusa BH, Piontek CM, Baab S. Verapamil treatment for women with bipolar disorder. Biol Psychiatry. 2002;51:745-752.
-
(2002)
Biol Psychiatry
, vol.51
, pp. 745-752
-
-
Wisner, K.L.1
Peindl, K.S.2
Perel, J.M.3
Hanusa, B.H.4
Piontek, C.M.5
Baab, S.6
-
86
-
-
84985823994
-
Secondary mania associated with diltiazem
-
Palat GK, Movahed A. Secondary mania associated with diltiazem. Clin Cardiol. 1985;8:251.
-
(1985)
Clin Cardiol
, vol.8
, pp. 251
-
-
Palat, G.K.1
Movahed, A.2
-
87
-
-
0029947207
-
Verapamil maintenance therapy in bipolar patients
-
Giannini AJ, Loiselle RH. Verapamil maintenance therapy in bipolar patients. J Clin Psychiatry. 1996;57:136.
-
(1996)
J Clin Psychiatry
, vol.57
, pp. 136
-
-
Giannini, A.J.1
Loiselle, R.H.2
-
88
-
-
0021747089
-
Verapamil as maintenance treatment in bipolar illness: A case report
-
Gitlin MJ, Weiss J. Verapamil as maintenance treatment in bipolar illness: a case report. J Clin Psychopharmacol. 1984;4:341-343.
-
(1984)
J Clin Psychopharmacol
, vol.4
, pp. 341-343
-
-
Gitlin, M.J.1
Weiss, J.2
-
90
-
-
34247232811
-
Preliminary controlled trial of nimodipine in ultra-rapid cycling affective dysregulation
-
Pazzaglia PJ, Post RM, Ketter TA, George MS, Marangell LB. Preliminary controlled trial of nimodipine in ultra-rapid cycling affective dysregulation. J Clin Psychopharmacol. 1987;7:101-103.
-
(1987)
J Clin Psychopharmacol
, vol.7
, pp. 101-103
-
-
Pazzaglia, P.J.1
Post, R.M.2
Ketter, T.A.3
George, M.S.4
Marangell, L.B.5
-
91
-
-
0023513449
-
Verapamil and lithium in maintenance therapy of manic patients
-
Giannini AJ, Verapamil and lithium in maintenance therapy of manic patients. J Clin Pharmacol. 1987;27:980-982.
-
(1987)
J Clin Pharmacol
, vol.27
, pp. 980-982
-
-
Giannini, A.J.1
-
92
-
-
0036915721
-
Calcium channel blocker, nimodipine, for the treatment of bipolar disorder during pregnancy
-
Yingling DR, Utter G, Vengalil S, Mason B. Calcium channel blocker, nimodipine, for the treatment of bipolar disorder during pregnancy. Am J Obstet Gynecol. 2002;187:1711-1712.
-
(2002)
Am J Obstet Gynecol
, vol.187
, pp. 1711-1712
-
-
Yingling, D.R.1
Utter, G.2
Vengalil, S.3
Mason, B.4
-
93
-
-
0031690746
-
Nimodipine monotherapy and carbamazepine augmentation in patients with refractory recurrent affective illness
-
Pazzaglia PJ, Post RM, Ketter TA, et al. Nimodipine monotherapy and carbamazepine augmentation in patients with refractory recurrent affective illness.J Clin Psychopharmacol. 1998;18:404-413.
-
(1998)
J Clin Psychopharmacol
, vol.18
, pp. 404-413
-
-
Pazzaglia, P.J.1
Post, R.M.2
Ketter, T.A.3
-
94
-
-
0028336696
-
Verapamil is not an antidepressant in patients resistant to tricyclic antidepressants
-
Adlersberg S, Toren P, Mester R, Rehavi M, Skolnick P, Weizman A. Verapamil is not an antidepressant in patients resistant to tricyclic antidepressants. Clin Neuropharmacol. 1994;17:294-297.
-
(1994)
Clin Neuropharmacol
, vol.17
, pp. 294-297
-
-
Adlersberg, S.1
Toren, P.2
Mester, R.3
Rehavi, M.4
Skolnick, P.5
Weizman, A.6
-
95
-
-
0035079933
-
Nicardipine improves the antidepressant action of ECT but does not improve cognition
-
Dubovsky SL, Buzan R, Thomas M, Kassner C, Cullum CM. Nicardipine improves the antidepressant action of ECT but does not improve cognition. J ECT. 2001;17:3-10.
-
(2001)
J ECT
, vol.17
, pp. 3-10
-
-
Dubovsky, S.L.1
Buzan, R.2
Thomas, M.3
Kassner, C.4
Cullum, C.M.5
-
96
-
-
0035072237
-
A double blind, randomized clinical trial assessing the efficacy and safety of augmenting standard antidepressant therapy with nimodipine in the treatment of 'vascular depression'
-
Taragano FE, Allegri R, Vicario A, Bagnatti P, Lyketsos CG. A double blind, randomized clinical trial assessing the efficacy and safety of augmenting standard antidepressant therapy with nimodipine in the treatment of 'vascular depression'. Int J Geriatr Psychiatry. 2001;16:254-260.
-
(2001)
Int J Geriatr Psychiatry
, vol.16
, pp. 254-260
-
-
Taragano, F.E.1
Allegri, R.2
Vicario, A.3
Bagnatti, P.4
Lyketsos, C.G.5
-
97
-
-
25844505517
-
A double-blind, randomized clinical trial to assess the augmentation with nimodipine of antidepressant therapy in the treatment of "vascular depression
-
Taragano FE, Bagnatti P, Allegri RF. A double-blind, randomized clinical trial to assess the augmentation with nimodipine of antidepressant therapy in the treatment of "vascular depression". Int Psychogeriatr. 2005;17:487-498.
-
(2005)
Int Psychogeriatr
, vol.17
, pp. 487-498
-
-
Taragano, F.E.1
Bagnatti, P.2
Allegri, R.F.3
-
98
-
-
0023908659
-
Controlled study of verapamil for treatment of panic disorder
-
Klein E, Uhde TW. Controlled study of verapamil for treatment of panic disorder. Am J Psychiatry 1988;145:431-434.
-
(1988)
Am J Psychiatry
, vol.145
, pp. 431-434
-
-
Klein, E.1
Uhde, T.W.2
-
99
-
-
0030455126
-
Calcium channel blockers for anxiety disorders?
-
Balon R, Ramesh C. Calcium channel blockers for anxiety disorders? Ann Clin Psychiatry. 1996;8:215-220.
-
(1996)
Ann Clin Psychiatry
, vol.8
, pp. 215-220
-
-
Balon, R.1
Ramesh, C.2
-
100
-
-
0014556238
-
Distribution and urinary excretion of furosemide in the rat
-
Seno S, Shaw SM, Christian JE. Distribution and urinary excretion of furosemide in the rat. J Pharm Sci. 1969;58:935-938.
-
(1969)
J Pharm Sci
, vol.58
, pp. 935-938
-
-
Seno, S.1
Shaw, S.M.2
Christian, J.E.3
-
101
-
-
0019311197
-
Thiazide-induced hypercalcemia in a manic-depressive patient
-
Gammon GD, Docherty JP. Thiazide-induced hypercalcemia in a manic-depressive patient. Am J Psychiatry. 1980;137:1453-1455.
-
(1980)
Am J Psychiatry
, vol.137
, pp. 1453-1455
-
-
Gammon, G.D.1
Docherty, J.P.2
-
102
-
-
4844228396
-
Clinical studies of thiazide-induced hyponatremia
-
Chow KM, Kwan BC, Szeto CC. Clinical studies of thiazide-induced hyponatremia. J Natl Med Assoc. 2004;96:1305-1308.
-
(2004)
J Natl Med Assoc
, vol.96
, pp. 1305-1308
-
-
Chow, K.M.1
Kwan, B.C.2
Szeto, C.C.3
-
103
-
-
0029964623
-
Reversible exogenous psychosis in thiazide-induced hyponatremia of 97 mmol/l [in German]
-
Haensch CA, Hennen G, Jorg J. Reversible exogenous psychosis in thiazide-induced hyponatremia of 97 mmol/l [in German]. Nervenarzt. 1996;67:319-322.
-
(1996)
Nervenarzt
, vol.67
, pp. 319-322
-
-
Haensch, C.A.1
Hennen, G.2
Jorg, J.3
-
104
-
-
1242339750
-
Severe hyponatremia associated with the combined use of thiazide diuretics and selective serotonin reuptake inhibitors
-
Rosner MH. Severe hyponatremia associated with the combined use of thiazide diuretics and selective serotonin reuptake inhibitors. Am J Med Sci. 2004;327:109-111.
-
(2004)
Am J Med Sci
, vol.327
, pp. 109-111
-
-
Rosner, M.H.1
-
105
-
-
0036119819
-
Hyponatremia in elderly psychiatric patients treated with Selective Serotonin Reuptake Inhibitors and venlafaxine: A retrospective controlled study in an inpatient unit
-
Kirby D, Ames D. Hyponatremia in elderly psychiatric patients treated with Selective Serotonin Reuptake Inhibitors and venlafaxine: a retrospective controlled study in an inpatient unit. Int J Geriatr Psychiatry. 2002;17:231-237.
-
(2002)
Int J Geriatr Psychiatry
, vol.17
, pp. 231-237
-
-
Kirby, D.1
Ames, D.2
-
106
-
-
0022239237
-
Depression after treatment with thiazide diuretics for hypertension
-
Okada F, Kirby D, Harrigan S, Ames D. Depression after treatment with thiazide diuretics for hypertension. Am J Psychiatry. 1985;142:1101-1102.
-
(1985)
Am J Psychiatry
, vol.142
, pp. 1101-1102
-
-
Okada, F.1
Kirby, D.2
Harrigan, S.3
Ames, D.4
-
107
-
-
0021866729
-
Diuretic-induced lithium toxicity presenting as mania
-
Nurnberger JI Jr. Diuretic-induced lithium toxicity presenting as mania. J Nerv Ment Dis. 1985;173:316-318.
-
(1985)
J Nerv Ment Dis
, vol.173
, pp. 316-318
-
-
Nurnberger Jr., J.I.1
-
108
-
-
0032766653
-
Drug-induced cognition disorders in the elderly: Incidence, prevention and management
-
Gray SL, Lai KV, Larson EB. Drug-induced cognition disorders in the elderly: incidence, prevention and management. Drug Saf. 1999;21:101-122.
-
(1999)
Drug Saf
, vol.21
, pp. 101-122
-
-
Gray, S.L.1
Lai, K.V.2
Larson, E.B.3
-
109
-
-
0842278743
-
Thiamine deficiency in congestive heart failure patients receiving long term furosemide therapy
-
Zenuk C, Healey J, Donnelly J, Vaillancourt R, Almalki Y, Smith S. Thiamine deficiency in congestive heart failure patients receiving long term furosemide therapy. Can J Clin Pharmacol. 2003;10:184-188.
-
(2003)
Can J Clin Pharmacol
, vol.10
, pp. 184-188
-
-
Zenuk, C.1
Healey, J.2
Donnelly, J.3
Vaillancourt, R.4
Almalki, Y.5
Smith, S.6
-
110
-
-
0344417101
-
Wernicke's encephalopathy induced by magnesium depletion
-
McLean J, Manchip S. Wernicke's encephalopathy induced by magnesium depletion. Lancet. 1999;353:1768.
-
(1999)
Lancet
, vol.353
, pp. 1768
-
-
McLean, J.1
Manchip, S.2
-
111
-
-
34247279922
-
-
Acetazolamide prescribing information. Hawthorne, NY: Taro Pharmaceuticals; 1997.
-
Acetazolamide prescribing information. Hawthorne, NY: Taro Pharmaceuticals; 1997.
-
-
-
-
112
-
-
0017744637
-
Carbonic anhydrase inhibitor side effects. Serum chemical analysis
-
Epstein DL, Grant WM. Carbonic anhydrase inhibitor side effects. Serum chemical analysis. Arch Opthalmol. 1977;95:1378-1382.
-
(1977)
Arch Opthalmol
, vol.95
, pp. 1378-1382
-
-
Epstein, D.L.1
Grant, W.M.2
-
113
-
-
0017339834
-
Acetazolamide delirium
-
Rowe TO. Acetazolamide delirium. Am J Psychiatry. 1977;134:587-588.
-
(1977)
Am J Psychiatry
, vol.134
, pp. 587-588
-
-
Rowe, T.O.1
-
114
-
-
0029026116
-
Acetazolamide toxicity and pharmacokinetics in patients receiving hemodialysis
-
Schwenk MH, St Peter WL, Meese MG, Singhal PC. Acetazolamide toxicity and pharmacokinetics in patients receiving hemodialysis. Pharmacotherapy. 1995;15:522-527.
-
(1995)
Pharmacotherapy
, vol.15
, pp. 522-527
-
-
Schwenk, M.H.1
St Peter, W.L.2
Meese, M.G.3
Singhal, P.C.4
-
115
-
-
3042673923
-
Acute confusional syndrome associated with obstructive sleep apnea aggravated by acidosis secondary to oral acetazolamide treatment [in Spanish]
-
Miguel E, Guell R, Anton A, Montiel JA, Mayos M. Acute confusional syndrome associated with obstructive sleep apnea aggravated by acidosis secondary to oral acetazolamide treatment [in Spanish]. Arch Bronconeumol. 2004;40:283-286.
-
(2004)
Arch Bronconeumol
, vol.40
, pp. 283-286
-
-
Miguel, E.1
Guell, R.2
Anton, A.3
Montiel, J.A.4
Mayos, M.5
-
116
-
-
0023830926
-
Effects of acetazolamide in patients with the sleep apnoea syndrome
-
Tojima H, Kunitomo F, Kimura H, Tatsumi K, Kuriyama T, Honda Y. Effects of acetazolamide in patients with the sleep apnoea syndrome. Thorax. 1988;43:113-119.
-
(1988)
Thorax
, vol.43
, pp. 113-119
-
-
Tojima, H.1
Kunitomo, F.2
Kimura, H.3
Tatsumi, K.4
Kuriyama, T.5
Honda, Y.6
-
117
-
-
31944441209
-
Acetazolamide improves central sleep apnea in heart failure: A double-blind, prospective study
-
Javaheri S. Acetazolamide improves central sleep apnea in heart failure: a double-blind, prospective study. Am J Respir Crit Care Med. 2006;173:234-237.
-
(2006)
Am J Respir Crit Care Med
, vol.173
, pp. 234-237
-
-
Javaheri, S.1
-
119
-
-
0028077161
-
Acetazolamide in bipolar affective disorders
-
Hayes SG. Acetazolamide in bipolar affective disorders. Ann Clin Psychiatry. 1994;6:91-98.
-
(1994)
Ann Clin Psychiatry
, vol.6
, pp. 91-98
-
-
Hayes, S.G.1
-
120
-
-
0021670332
-
Antipsychotic and prophylactic effects of acetazolamide (Diamox) on atypical psychosis
-
Inoue H, Hazama H, Hamazoe K, et al. Antipsychotic and prophylactic effects of acetazolamide (Diamox) on atypical psychosis. Folia Psychiatr Neurol Jpn. 1984;38:425-436.
-
(1984)
Folia Psychiatr Neurol Jpn
, vol.38
, pp. 425-436
-
-
Inoue, H.1
Hazama, H.2
Hamazoe, K.3
-
121
-
-
34247199107
-
-
Catapres-TTS (clonidine) prescribing information. Indianapolis, Ind: Boeringer-Mannheim; 2006.
-
Catapres-TTS (clonidine) prescribing information. Indianapolis, Ind: Boeringer-Mannheim; 2006.
-
-
-
-
122
-
-
0037344546
-
Neuropsychiatric effects of cardiovascular drug therapy
-
Keller S, Frishman WH. Neuropsychiatric effects of cardiovascular drug therapy. Cardiol Rev. 2003;11:73-93.
-
(2003)
Cardiol Rev
, vol.11
, pp. 73-93
-
-
Keller, S.1
Frishman, W.H.2
-
123
-
-
0020416916
-
Psychiatric side effects of antihypertensive drugs other than reserpine
-
Paykel ES, Fleminger R, Watson JP. Psychiatric side effects of antihypertensive drugs other than reserpine. J Clin Psychopharmacol. 1982;2:14-39.
-
(1982)
J Clin Psychopharmacol
, vol.2
, pp. 14-39
-
-
Paykel, E.S.1
Fleminger, R.2
Watson, J.P.3
-
124
-
-
0017683357
-
Acute hallucinosis due to clonidine
-
Enoch MD, Hammad GE. Acute hallucinosis due to clonidine. Curr Med Res Opin. 1977;4:670-671.
-
(1977)
Curr Med Res Opin
, vol.4
, pp. 670-671
-
-
Enoch, M.D.1
Hammad, G.E.2
-
127
-
-
0032695861
-
A meta-analysis of clonidine for symptoms of attention deficit hyperactivity disorder
-
Conner D, Fletcher K, Swanson J. A meta-analysis of clonidine for symptoms of attention deficit hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 1999;58:1551-1559.
-
(1999)
J Am Acad Child Adolesc Psychiatry
, vol.58
, pp. 1551-1559
-
-
Conner, D.1
Fletcher, K.2
Swanson, J.3
-
128
-
-
0037176827
-
Treatment of ADHD in children with tics: A randomized controlled trial
-
Kurlan R. Treatment of ADHD in children with tics: a randomized controlled trial. Neurology. 2002;58:527-536.
-
(2002)
Neurology
, vol.58
, pp. 527-536
-
-
Kurlan, R.1
-
129
-
-
27744598976
-
Attention-deficit/ hyperactivity disorder among adolescents: A review of the diagnosis, treatment, and clinical implications
-
Wolraich ML, Wibbelsman CI, Brown TE, et al. Attention-deficit/ hyperactivity disorder among adolescents: a review of the diagnosis, treatment, and clinical implications. Pediatrics. 2005;115:1734-1746.
-
(2005)
Pediatrics
, vol.115
, pp. 1734-1746
-
-
Wolraich, M.L.1
Wibbelsman, C.I.2
Brown, T.E.3
-
131
-
-
23944485969
-
Anesthesia-assisted vs buprenorphine- or clonidine-assisted heroin detoxification and naltrexone induction: A randomized trial
-
Collins ED, Kleber HD, Whittington RA, Heitler NE. Anesthesia-assisted vs buprenorphine- or clonidine-assisted heroin detoxification and naltrexone induction: a randomized trial. JAMA. 2005;294:903-913.
-
(2005)
JAMA
, vol.294
, pp. 903-913
-
-
Collins, E.D.1
Kleber, H.D.2
Whittington, R.A.3
Heitler, N.E.4
-
133
-
-
0023202244
-
Clonidine vs chlordiazepoxide in the management of acute alcohol withdrawal syndrome
-
Baumgartner GR, Rowen RC. Clonidine vs chlordiazepoxide in the management of acute alcohol withdrawal syndrome. Arch Intern Med. 1987;147:1223-1226.
-
(1987)
Arch Intern Med
, vol.147
, pp. 1223-1226
-
-
Baumgartner, G.R.1
Rowen, R.C.2
-
134
-
-
0023479375
-
Clonidine and alcohol withdrawal
-
Review
-
Cushman P Jr. Clonidine and alcohol withdrawal. Adv Alcohol Subst Abuse. 1987;7:17-28. Review.
-
(1987)
Adv Alcohol Subst Abuse
, vol.7
, pp. 17-28
-
-
Cushman Jr., P.1
-
136
-
-
0028269249
-
Treatment of alcohol withdrawal syndrome
-
Review
-
Ozdemir V, Bremner KE, Naranjo CA. Treatment of alcohol withdrawal syndrome. Ann Med. 1994;26:101-105. Review.
-
(1994)
Ann Med
, vol.26
, pp. 101-105
-
-
Ozdemir, V.1
Bremner, K.E.2
Naranjo, C.A.3
-
137
-
-
0035692207
-
Pharmacological options for the treatment of Tourette's disorder
-
Review
-
Jimenez-Jimenez FJ, Garcia-Ruiz PJ. Pharmacological options for the treatment of Tourette's disorder. Drugs. 2001;61:2207-2220. Review.
-
(2001)
Drugs
, vol.61
, pp. 2207-2220
-
-
Jimenez-Jimenez, F.J.1
Garcia-Ruiz, P.J.2
-
138
-
-
0033667056
-
Gilles de la Tourette syndrome: Symptomatic treatment based on evidence
-
Review
-
Robertson MM, Stern JS. Gilles de la Tourette syndrome: symptomatic treatment based on evidence. Eur Child Adolesc Psychiatry. 2000;9 Suppl 1:160-715. Review.
-
(2000)
Eur Child Adolesc Psychiatry
, vol.9
, Issue.SUPPL. 1
, pp. 160-715
-
-
Robertson, M.M.1
Stern, J.S.2
-
139
-
-
0025907779
-
Clonidine treatment of Gilles de la Tourette's syndrome
-
Leckman JF, Hardin MT, Riddle MA, Stevenson J, Ort SI, Cohen DJ. Clonidine treatment of Gilles de la Tourette's syndrome. Arch Gen Psychiatry. 1991;48:324-328.
-
(1991)
Arch Gen Psychiatry
, vol.48
, pp. 324-328
-
-
Leckman, J.F.1
Hardin, M.T.2
Riddle, M.A.3
Stevenson, J.4
Ort, S.I.5
Cohen, D.J.6
-
140
-
-
0036511510
-
Risperidone versus clonidine in the treatment of children and adolescents with Tourette's syndrome
-
Gaffney GR, Perry PJ, Lund BC, Bever-Stille KA, Arndt S, Kuperman S. Risperidone versus clonidine in the treatment of children and adolescents with Tourette's syndrome. J Am Acad Child Adolesc Psychiatry. 2002;41:330-336.
-
(2002)
J Am Acad Child Adolesc Psychiatry
, vol.41
, pp. 330-336
-
-
Gaffney, G.R.1
Perry, P.J.2
Lund, B.C.3
Bever-Stille, K.A.4
Arndt, S.5
Kuperman, S.6
-
141
-
-
0020440284
-
Clonidine in the treatment of Tourette syndrome: A review of data
-
Leckman JF, Cohen DJ, Detlor J, Young JG, Harcherik D, Shaywitz BA. Clonidine in the treatment of Tourette syndrome: a review of data. Adv Neurol. 1982;35:391-401.
-
(1982)
Adv Neurol
, vol.35
, pp. 391-401
-
-
Leckman, J.F.1
Cohen, D.J.2
Detlor, J.3
Young, J.G.4
Harcherik, D.5
Shaywitz, B.A.6
-
142
-
-
0018856249
-
Memory enhancement in Korsakoff's psychosis by clonidine: Further evidence for a noradrenergic deficit
-
McEntee WJ, Mair RG. Memory enhancement in Korsakoff's psychosis by clonidine: further evidence for a noradrenergic deficit. Ann Neurol. 1980;7:466-470.
-
(1980)
Ann Neurol
, vol.7
, pp. 466-470
-
-
McEntee, W.J.1
Mair, R.G.2
-
143
-
-
0026183418
-
The effect of clonidine in the treatment of acute mania
-
Tudorache B, Diacicov S. The effect of clonidine in the treatment of acute mania. Rom J Neurol Psychiatry. 1991;29:209-213.
-
(1991)
Rom J Neurol Psychiatry
, vol.29
, pp. 209-213
-
-
Tudorache, B.1
Diacicov, S.2
-
144
-
-
0031005348
-
Psychopharmacologic treatment of pathologic aggression
-
Fava M. Psychopharmacologic treatment of pathologic aggression. Psychiatr Clin North Am. 1997;20:427-51.
-
(1997)
Psychiatr Clin North Am
, vol.20
, pp. 427-451
-
-
Fava, M.1
-
145
-
-
0023472869
-
Effects of antihypertensive medications on vitality and well-being
-
Levine S, Croog SH, Sudilovsky A, Testa MA. Effects of antihypertensive medications on vitality and well-being. J Fam Pract. 1987;25:357-363.
-
(1987)
J Fam Pract
, vol.25
, pp. 357-363
-
-
Levine, S.1
Croog, S.H.2
Sudilovsky, A.3
Testa, M.A.4
-
146
-
-
0025366197
-
Self-reported side effects from antihypertensive drugs. A clinical trial. Quality of Life Research Group
-
Schoenberger JA, Croog SH, Sudilovsky A, Levine S, Baume RM. Self-reported side effects from antihypertensive drugs. A clinical trial. Quality of Life Research Group. Am J Hypertens. 1990;3:123-132.
-
(1990)
Am J Hypertens
, vol.3
, pp. 123-132
-
-
Schoenberger, J.A.1
Croog, S.H.2
Sudilovsky, A.3
Levine, S.4
Baume, R.M.5
-
147
-
-
0016166418
-
Methyldopa-induced decrease in mental activity
-
Adler S. Methyldopa-induced decrease in mental activity. JAMA. 1974;230:1428-1429.
-
(1974)
JAMA
, vol.230
, pp. 1428-1429
-
-
Adler, S.1
-
148
-
-
0023493598
-
Neuropsychological effects of antihypertensive drugs
-
Wurzelmann J, Frishman WH, Aronson M, Masur D, Ooi WL. Neuropsychological effects of antihypertensive drugs. Cardiol Clin. 1987;5:689-701.
-
(1987)
Cardiol Clin
, vol.5
, pp. 689-701
-
-
Wurzelmann, J.1
Frishman, W.H.2
Aronson, M.3
Masur, D.4
Ooi, W.L.5
-
149
-
-
0036668209
-
Effects of six anti-hypertensive medications on cognitive performance
-
Muldoon MF, Waldstein SR, Ryan CM, et al. Effects of six anti-hypertensive medications on cognitive performance. J Hypertens. 2002;20:1643-1652.
-
(2002)
J Hypertens
, vol.20
, pp. 1643-1652
-
-
Muldoon, M.F.1
Waldstein, S.R.2
Ryan, C.M.3
-
150
-
-
0018179190
-
Antihypertensive drugs and depression: A reappraisal
-
Bant WP. Antihypertensive drugs and depression: a reappraisal. Psychol Med. 1978;8:275-283.
-
(1978)
Psychol Med
, vol.8
, pp. 275-283
-
-
Bant, W.P.1
-
151
-
-
0019489448
-
Psychiatric complications of antihypertensive medications
-
Pottash AL, Black HR, Gold MS. Psychiatric complications of antihypertensive medications. J Nerv Ment Dis. 1981;169:430-438.
-
(1981)
J Nerv Ment Dis
, vol.169
, pp. 430-438
-
-
Pottash, A.L.1
Black, H.R.2
Gold, M.S.3
-
152
-
-
0014109483
-
Depression with the use of alpha-methyldopa
-
McKinney WT Jr, Kane FJ Jr. Depression with the use of alpha-methyldopa. Am J Psychiatry. 1967;124:80-81.
-
(1967)
Am J Psychiatry
, vol.124
, pp. 80-81
-
-
McKinney Jr, W.T.1
Kane Jr., F.J.2
-
153
-
-
0027730558
-
Critical review of data supporting affective disorder caused by nonpsychotropic medication
-
Long TD, Kathol RG. Critical review of data supporting affective disorder caused by nonpsychotropic medication. Ann Clin Psychiatry. 1993;5:259-270.
-
(1993)
Ann Clin Psychiatry
, vol.5
, pp. 259-270
-
-
Long, T.D.1
Kathol, R.G.2
-
154
-
-
0020567453
-
Alpha-methyldopa and depression: A clinical study and review of the literature
-
DeMuth GW, Ackerman SH. Alpha-methyldopa and depression: a clinical study and review of the literature. Am J Psychiatry. 1983;140:534-538.
-
(1983)
Am J Psychiatry
, vol.140
, pp. 534-538
-
-
DeMuth, G.W.1
Ackerman, S.H.2
-
155
-
-
0015789188
-
A therapeutic paradox? Combined treatment of Parkinson's disease with levodopa and methyldopa
-
Kofman OS. A therapeutic paradox? Combined treatment of Parkinson's disease with levodopa and methyldopa. Arch Neurol. 1973;29:120-121.
-
(1973)
Arch Neurol
, vol.29
, pp. 120-121
-
-
Kofman, O.S.1
-
156
-
-
0015259415
-
Methyldopa as an adjunct to levodopa treatment of Parkinson's disease
-
Sweet RD, Lee JE, McDowell FH. Methyldopa as an adjunct to levodopa treatment of Parkinson's disease. Clin Pharmacol Ther. 1972;13:23-27.
-
(1972)
Clin Pharmacol Ther
, vol.13
, pp. 23-27
-
-
Sweet, R.D.1
Lee, J.E.2
McDowell, F.H.3
-
157
-
-
0015169546
-
Alpha-methyldopa as an adjunct to levodopa treatment of Parkinson's disease
-
Sweet RD, Lee JE, McDowell F. Alpha-methyldopa as an adjunct to levodopa treatment of Parkinson's disease. Trans Am Neurol Assoc. 1971;96:59-65.
-
(1971)
Trans Am Neurol Assoc
, vol.96
, pp. 59-65
-
-
Sweet, R.D.1
Lee, J.E.2
McDowell, F.3
-
158
-
-
0018128466
-
Paranoid-hallucinatory state induced in a depressive patient by methyldopa: A case report
-
Endo M, Hirai K, Ohara M. Paranoid-hallucinatory state induced in a depressive patient by methyldopa: a case report. Psychoneuroendocrinology. 1978;3:211-215.
-
(1978)
Psychoneuroendocrinology
, vol.3
, pp. 211-215
-
-
Endo, M.1
Hirai, K.2
Ohara, M.3
-
159
-
-
0017169314
-
Acute organic brain syndrome psychosis with methyldopa therapy: Case report
-
Hawkins DJ. Acute organic brain syndrome psychosis with methyldopa therapy: case report. Mo Med. 1976;73:476, 481.
-
(1976)
Mo Med
, vol.73
, Issue.476
, pp. 481
-
-
Hawkins, D.J.1
-
160
-
-
0001705757
-
Depressive reactions in hypertensive patients; a comparison of those treated with Rauwolfia and those receiving no specific antihypertensive treatment
-
Quetsch RM, Achor RW, Litin EM, Faucett RL. Depressive reactions in hypertensive patients; a comparison of those treated with Rauwolfia and those receiving no specific antihypertensive treatment. Circulation. 1959;19:366-375.
-
(1959)
Circulation
, vol.19
, pp. 366-375
-
-
Quetsch, R.M.1
Achor, R.W.2
Litin, E.M.3
Faucett, R.L.4
-
161
-
-
0012604122
-
Treatment of hypertensive patients with Rauwolfia compounds and reserpine; depressive and psychotic changes
-
Kass I, Brown EC. Treatment of hypertensive patients with Rauwolfia compounds and reserpine; depressive and psychotic changes. JAMA. 1955;159:1513-1516.
-
(1955)
JAMA
, vol.159
, pp. 1513-1516
-
-
Kass, I.1
Brown, E.C.2
-
162
-
-
0012604123
-
Drug-induced depression; fact or fallacy
-
Ayd FJ Jr. Drug-induced depression; fact or fallacy. N Y State J Med. 1958;58:354-356.
-
(1958)
N Y State J Med
, vol.58
, pp. 354-356
-
-
Ayd Jr., F.J.1
-
163
-
-
84959070165
-
Mental depression in hypertensive patients treated for long periods with large doses of reserpine
-
Fries ED. Mental depression in hypertensive patients treated for long periods with large doses of reserpine. N Engl J Med. 1954;251:1006-1008.
-
(1954)
N Engl J Med
, vol.251
, pp. 1006-1008
-
-
Fries, E.D.1
-
164
-
-
0026014277
-
Neuropsychiatric considerations in the treatment of hypertension
-
Rauch SL, Stern TA, Zusman RM. Neuropsychiatric considerations in the treatment of hypertension. Int J Psychiatry Med. 1991;21:291-308.
-
(1991)
Int J Psychiatry Med
, vol.21
, pp. 291-308
-
-
Rauch, S.L.1
Stern, T.A.2
Zusman, R.M.3
-
165
-
-
0028006802
-
Impact of the treatment of isolated systolic hypertension on behavioral variables. Results from the systolic hypertension in the elderly program
-
Applegate WB, Pressel S, Wittes J, et al. Impact of the treatment of isolated systolic hypertension on behavioral variables. Results from the systolic hypertension in the elderly program. Arch Intern Med. 1994;154:2154-2160.
-
(1994)
Arch Intern Med
, vol.154
, pp. 2154-2160
-
-
Applegate, W.B.1
Pressel, S.2
Wittes, J.3
-
166
-
-
0025219286
-
Treatment of hypertension in the elderly: II. Cognitive and behavioral function. Results of a Department of Veterans Affairs Cooperative Study
-
Goldstein G, Materson BJ, Cushman WC, et al. Treatment of hypertension in the elderly: II. Cognitive and behavioral function. Results of a Department of Veterans Affairs Cooperative Study. Hypertension. 1990;15:361-369.
-
(1990)
Hypertension
, vol.15
, pp. 361-369
-
-
Goldstein, G.1
Materson, B.J.2
Cushman, W.C.3
-
167
-
-
0029787839
-
Aspects of tolerability of centrally acting antihypertensive drugs
-
Webster J, Koch HF. Aspects of tolerability of centrally acting antihypertensive drugs. J Cardiovasc Pharmacol. 1996;27(suppl 3):S49-S54.
-
(1996)
J Cardiovasc Pharmacol
, vol.27
, Issue.SUPPL. 3
-
-
Webster, J.1
Koch, H.F.2
-
168
-
-
0022292736
-
Biobehavioral sequellae associated with adrenergic-inhibiting antihypertensive agents: A critical review
-
Rosen RC, Kostis JB. Biobehavioral sequellae associated with adrenergic-inhibiting antihypertensive agents: a critical review. Health Psychol. 1985;4:579-604.
-
(1985)
Health Psychol
, vol.4
, pp. 579-604
-
-
Rosen, R.C.1
Kostis, J.B.2
-
169
-
-
0043132076
-
The myth of reserpine-induced depression: Role in the historical development of the monoamine hypothesis
-
Aumeister AA, Hawkins MF, Uzelac SM. The myth of reserpine-induced depression: role in the historical development of the monoamine hypothesis. J Hist Neurosci. 2003;12:207-220.
-
(2003)
J Hist Neurosci
, vol.12
, pp. 207-220
-
-
Aumeister, A.A.1
Hawkins, M.F.2
Uzelac, S.M.3
-
170
-
-
0032766653
-
Drug-induced cognition disorders in the elderly: Incidence, prevention and management
-
Gray SL, Lai KV, Larson EB. Drug-induced cognition disorders in the elderly: incidence, prevention and management. Drug Saf. 1999;21:101-122.
-
(1999)
Drug Saf
, vol.21
, pp. 101-122
-
-
Gray, S.L.1
Lai, K.V.2
Larson, E.B.3
-
171
-
-
0025951899
-
Depression associated with antihypertensive drugs
-
Prisant LM, Spruill WJ, Fincham JE, Wade WE, Carr AA, Adams MA. Depression associated with antihypertensive drugs. J Fam Pract. 1991;33:481-485.
-
(1991)
J Fam Pract
, vol.33
, pp. 481-485
-
-
Prisant, L.M.1
Spruill, W.J.2
Fincham, J.E.3
Wade, W.E.4
Carr, A.A.5
Adams, M.A.6
-
172
-
-
0019948154
-
Reserpine withdrawal psychosis: The possible role of denervation supersensitivity of receptors
-
Kent TA, Wilber RD. Reserpine withdrawal psychosis: the possible role of denervation supersensitivity of receptors. J Nerv Ment Dis. 1982;170:502-504.
-
(1982)
J Nerv Ment Dis
, vol.170
, pp. 502-504
-
-
Kent, T.A.1
Wilber, R.D.2
-
175
-
-
0018421733
-
Lithium plus reserpine in refractory manic patients
-
Bacher NM, Lewis HA. Lithium plus reserpine in refractory manic patients. Am J Psychiatry. 1979;136:811-814.
-
(1979)
Am J Psychiatry
, vol.136
, pp. 811-814
-
-
Bacher, N.M.1
Lewis, H.A.2
-
176
-
-
34247190828
-
The effect of reserpine on the duration of manic attacks
-
Watt DC. The effect of reserpine on the duration of manic attacks. J Neurol Neurosurg Psychiatry. 1958;21:297-300.
-
(1958)
J Neurol Neurosurg Psychiatry
, vol.21
, pp. 297-300
-
-
Watt, D.C.1
-
178
-
-
0030463907
-
Risperidone-reserpine combination in refractory psychosis
-
Solon EN. Risperidone-reserpine combination in refractory psychosis. Schizophr Res. 1996;22:265-266.
-
(1996)
Schizophr Res
, vol.22
, pp. 265-266
-
-
Solon, E.N.1
-
179
-
-
0022384284
-
Reserpine and phencyclidine-associated psychosis: Three case reports
-
Berlant JL. Reserpine and phencyclidine-associated psychosis: three case reports. J Clin Psychiatry. 1985;46:542-544.
-
(1985)
J Clin Psychiatry
, vol.46
, pp. 542-544
-
-
Berlant, J.L.1
-
180
-
-
0022538473
-
Neuroleptics and reserpine in refractory psychoses
-
Berlant JL. Neuroleptics and reserpine in refractory psychoses. J Clin Psychopharmacol. 1986;6:180-184.
-
(1986)
J Clin Psychopharmacol
, vol.6
, pp. 180-184
-
-
Berlant, J.L.1
-
181
-
-
0023195609
-
Reserpine augmentation of desipramine in refractory depression: Clinical and neurobiological effects
-
Price LH, Charney DS, Heninger GR. Reserpine augmentation of desipramine in refractory depression: clinical and neurobiological effects. Psychopharmacology (Berl). 1987;92:431-437.
-
(1987)
Psychopharmacology (Berl)
, vol.92
, pp. 431-437
-
-
Price, L.H.1
Charney, D.S.2
Heninger, G.R.3
-
182
-
-
0028173804
-
Adverse effects of alpha 1-adrenergic blocking drugs
-
Carruthers SG. Adverse effects of alpha 1-adrenergic blocking drugs. Drug Saf. 1994;11:12-20.
-
(1994)
Drug Saf
, vol.11
, pp. 12-20
-
-
Carruthers, S.G.1
-
183
-
-
11144248215
-
Doxazosin for treating lower urinary tract symptoms compatible with benign prostatic obstruction: A systematic review of efficacy and adverse effects
-
MacDonald R, Wilt TJ, Howe RW. Doxazosin for treating lower urinary tract symptoms compatible with benign prostatic obstruction: a systematic review of efficacy and adverse effects. BJU Int. 2004;94:1263-1270.
-
(2004)
BJU Int
, vol.94
, pp. 1263-1270
-
-
MacDonald, R.1
Wilt, T.J.2
Howe, R.W.3
-
184
-
-
2342423800
-
Extended-release alfuzosin hydrochloride: A new alpha-adrenergic receptor antagonist for symptomatic benign prostatic hyperplasia
-
Guay DR. Extended-release alfuzosin hydrochloride: a new alpha-adrenergic receptor antagonist for symptomatic benign prostatic hyperplasia. Am J Geriatr Pharmacother. 2004;2:14-23.
-
(2004)
Am J Geriatr Pharmacother
, vol.2
, pp. 14-23
-
-
Guay, D.R.1
-
185
-
-
0025633678
-
Antihypertensive medications and depression
-
Beers MH, Passman LJ. Antihypertensive medications and depression. Drugs. 1990;40:792-799.
-
(1990)
Drugs
, vol.40
, pp. 792-799
-
-
Beers, M.H.1
Passman, L.J.2
-
186
-
-
33644920665
-
Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism
-
Pessina AC, Ciccariello L, Perrone F, et al. Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism. Nutr Metab Cardiovasc Dis. 2006;16:137-147.
-
(2006)
Nutr Metab Cardiovasc Dis
, vol.16
, pp. 137-147
-
-
Pessina, A.C.1
Ciccariello, L.2
Perrone, F.3
-
187
-
-
0020761291
-
Neuropsychiatric manifestations of antihypertensive medications
-
Benson D, Peterson LG, Bartay J. Neuropsychiatric manifestations of antihypertensive medications. Psychiatr Med. 1983;1:205-214.
-
(1983)
Psychiatr Med
, vol.1
, pp. 205-214
-
-
Benson, D.1
Peterson, L.G.2
Bartay, J.3
-
188
-
-
85007686092
-
Drug induced psychosis with doxazosin
-
Evans M, Perera PW, Donoghue J. Drug induced psychosis with doxazosin. BMJ. 1997;314:1869.
-
(1997)
BMJ
, vol.314
, pp. 1869
-
-
Evans, M.1
Perera, P.W.2
Donoghue, J.3
-
189
-
-
0022970473
-
Neuropsychiatric complications related to use of prazosin in patients with renal failure
-
Chin DKF Cho Ak, Tse CY. Neuropsychiatric complications related to use of prazosin in patients with renal failure. BMJ. 1986; 293:1347.
-
(1986)
BMJ
, vol.293
, pp. 1347
-
-
Chin, D.K.F.1
Cho, A.2
Tse, C.Y.3
-
190
-
-
0024591107
-
Effects of antihypertensive therapy on blood pressure control, cognition, and reactivity. A placebo-controlled comparison of prazosin, propranolol, and hydrochlorothiazide
-
Lasser NL, Nash J, Lasser VI, Hamill SJ, Batey DM. Effects of antihypertensive therapy on blood pressure control, cognition, and reactivity. A placebo-controlled comparison of prazosin, propranolol, and hydrochlorothiazide. Am J Med. 1989;86:98-103.
-
(1989)
Am J Med
, vol.86
, pp. 98-103
-
-
Lasser, N.L.1
Nash, J.2
Lasser, V.I.3
Hamill, S.J.4
Batey, D.M.5
-
191
-
-
0037315260
-
Reduction of nightmares and other PTSD symptoms in combat veterans by prazosin: A placebo-controlled study
-
Raskind MA, Peskind ER, Kanter ED, et al. Reduction of nightmares and other PTSD symptoms in combat veterans by prazosin: a placebo-controlled study. Am J Psychiatry. 2003;160:371-373.
-
(2003)
Am J Psychiatry
, vol.160
, pp. 371-373
-
-
Raskind, M.A.1
Peskind, E.R.2
Kanter, E.D.3
-
192
-
-
0036007450
-
The alpha1-adrenergic antagonist prazosin improves sleep and nightmares in civilian trauma posttraumatic stress disorder
-
Taylor F, Raskind MA. The alpha1-adrenergic antagonist prazosin improves sleep and nightmares in civilian trauma posttraumatic stress disorder. J Clin Psychopharmacol. 2002;22:82-85.
-
(2002)
J Clin Psychopharmacol
, vol.22
, pp. 82-85
-
-
Taylor, F.1
Raskind, M.A.2
-
193
-
-
0242596600
-
Prazosin reduces trauma-related nightmares in older men with chronic posttraumatic stress disorder
-
Peskind ER, Bonner LT, Hoff DJ, Raskind MA. Prazosin reduces trauma-related nightmares in older men with chronic posttraumatic stress disorder. J Geriatr Psychiatry Neurol. 2003;16:165-671.
-
(2003)
J Geriatr Psychiatry Neurol
, vol.16
, pp. 165-671
-
-
Peskind, E.R.1
Bonner, L.T.2
Hoff, D.J.3
Raskind, M.A.4
-
194
-
-
0036076451
-
Prazosin reduces nightmares in combat veterans with posttraumatic stress disorder
-
Raskind MA, Thompson C, Petrie EC, et al. Prazosin reduces nightmares in combat veterans with posttraumatic stress disorder. J Clin Psychiatry. 2002;63:565-568.
-
(2002)
J Clin Psychiatry
, vol.63
, pp. 565-568
-
-
Raskind, M.A.1
Thompson, C.2
Petrie, E.C.3
-
195
-
-
33745610463
-
Sleep disturbances in patients with post-traumatic stress disorder: Epidemiology, impact and approaches to management
-
Maher MJ, Rego SA, Asnis GM. Sleep disturbances in patients with post-traumatic stress disorder: epidemiology, impact and approaches to management. CNS Drugs. 2006;20:567-590.
-
(2006)
CNS Drugs
, vol.20
, pp. 567-590
-
-
Maher, M.J.1
Rego, S.A.2
Asnis, G.M.3
-
196
-
-
33644820533
-
Daytime prazosin reduces psychological distress to trauma specific cues in civilian trauma posttraumatic stress disorder
-
Taylor FB, Lowe K, Thompson C, et al. Daytime prazosin reduces psychological distress to trauma specific cues in civilian trauma posttraumatic stress disorder. Biol Psychiatry. 2006;59:577-581.
-
(2006)
Biol Psychiatry
, vol.59
, pp. 577-581
-
-
Taylor, F.B.1
Lowe, K.2
Thompson, C.3
-
197
-
-
34247275399
-
The dual risks of depression and hypertension: Treatment of coexisting disorders requires vigilance
-
online, Available at:, Accessed December
-
Shrivastava S, Kochar MS. The dual risks of depression and hypertension: treatment of coexisting disorders requires vigilance. Postgrad Med [online]. Available at: http://www.postgradmed.com/issues/2002/06_02/ shrivastava.htm. Accessed December 2006.
-
(2006)
Postgrad Med
-
-
Shrivastava, S.1
Kochar, M.S.2
-
198
-
-
0020510918
-
Propranolol-hydralazine combination in essential hypertension
-
Stevens JD, Binstok G, Mullane JF, et al. Propranolol-hydralazine combination in essential hypertension. Clin Ther. 1983;5:525-539.
-
(1983)
Clin Ther
, vol.5
, pp. 525-539
-
-
Stevens, J.D.1
Binstok, G.2
Mullane, J.F.3
-
199
-
-
34247215243
-
Acute psychosis as a complication of hydralazine therapy in essential hypertension
-
Moser M, Syner J, Malitz S, Mattingly TW. Acute psychosis as a complication of hydralazine therapy in essential hypertension. JAMA. 1953;152:1329-1331.
-
(1953)
JAMA
, vol.152
, pp. 1329-1331
-
-
Moser, M.1
Syner, J.2
Malitz, S.3
Mattingly, T.W.4
-
200
-
-
0018746416
-
Precipitation of heart failure following sudden withdrawal of hydralazine
-
Black JR, Mehta J. Precipitation of heart failure following sudden withdrawal of hydralazine. Chest. 1979;75:724-725.
-
(1979)
Chest
, vol.75
, pp. 724-725
-
-
Black, J.R.1
Mehta, J.2
-
201
-
-
0025219286
-
Treatment of hypertension in the elderly: II. Cognitive and behavioral function. Results of a Department of Veterans Affairs Cooperative Study
-
Goldstein G, Materson BJ, Cushman WC, et al. Treatment of hypertension in the elderly: II. Cognitive and behavioral function. Results of a Department of Veterans Affairs Cooperative Study. Hypertension. 1990;15:361-369.
-
(1990)
Hypertension
, vol.15
, pp. 361-369
-
-
Goldstein, G.1
Materson, B.J.2
Cushman, W.C.3
-
202
-
-
30844473089
-
Drug-induced lupus erythematosus
-
Sarzi-Puttini P, Atzeni F, Capsoni F, Lubrano E, Doria A. Drug-induced lupus erythematosus. Autoimmunity. 2005;38:507-518.
-
(2005)
Autoimmunity
, vol.38
, pp. 507-518
-
-
Sarzi-Puttini, P.1
Atzeni, F.2
Capsoni, F.3
Lubrano, E.4
Doria, A.5
-
203
-
-
0014036588
-
Clinical and experimental studies on the hydralazine syndrome and its relationship to systemic lupus erythematosus
-
Alarcon-Segovia D, Wakim KG, Worthington JW, Ward LE. Clinical and experimental studies on the hydralazine syndrome and its relationship to systemic lupus erythematosus. Medicine (Baltimore). 1967;46:1-33.
-
(1967)
Medicine (Baltimore)
, vol.46
, pp. 1-33
-
-
Alarcon-Segovia, D.1
Wakim, K.G.2
Worthington, J.W.3
Ward, L.E.4
-
204
-
-
0028815763
-
Sodium nitroprusside-induced delirium
-
Harmon C, Wohlreich MM. Sodium nitroprusside-induced delirium. Psychosomatics. 1995;36:83-85.
-
(1995)
Psychosomatics
, vol.36
, pp. 83-85
-
-
Harmon, C.1
Wohlreich, M.M.2
-
205
-
-
0023626057
-
Visual hallucinations and suicidal ideation attributed to isosorbide dinitrate
-
Rosenthal R. Visual hallucinations and suicidal ideation attributed to isosorbide dinitrate. Psychosomatics. 1987;28:555-556.
-
(1987)
Psychosomatics
, vol.28
, pp. 555-556
-
-
Rosenthal, R.1
-
206
-
-
0016474953
-
Hospital-acquired salicylate intoxication, report of a case with psychosis, acidosis, and coma
-
Good AE, Welch MH. Hospital-acquired salicylate intoxication, report of a case with psychosis, acidosis, and coma. J Rheumatol. 1975;2:52-60.
-
(1975)
J Rheumatol
, vol.2
, pp. 52-60
-
-
Good, A.E.1
Welch, M.H.2
-
207
-
-
34247234699
-
Acute toxic psychosis due to acetyl-salicylic acid
-
Sawrer-Foner GJ, Morrison GH. Acute toxic psychosis due to acetyl-salicylic acid. Can Serv Med J. 1955;11:599-606.
-
(1955)
Can Serv Med J
, vol.11
, pp. 599-606
-
-
Sawrer-Foner, G.J.1
Morrison, G.H.2
-
208
-
-
0026478215
-
Salicylate intoxication in the elderly. Recognition and recommendations on how to prevent it
-
Durnas C, Cusack BJ. Salicylate intoxication in the elderly. Recognition and recommendations on how to prevent it. Drugs Aging. 1992;2:20-34.
-
(1992)
Drugs Aging
, vol.2
, pp. 20-34
-
-
Durnas, C.1
Cusack, B.J.2
-
209
-
-
0242299634
-
Rationale for a trial of low-dose aspirin for the primary prevention of major adverse cardiovascular events and vascular dementia in the elderly: Aspirin in Reducing Events in the Elderly (ASPREE)
-
Nelson M, Reid C, Beilin L, et al. Rationale for a trial of low-dose aspirin for the primary prevention of major adverse cardiovascular events and vascular dementia in the elderly: Aspirin in Reducing Events in the Elderly (ASPREE). Drugs Aging. 2003;20:897-903.
-
(2003)
Drugs Aging
, vol.20
, pp. 897-903
-
-
Nelson, M.1
Reid, C.2
Beilin, L.3
-
210
-
-
0033788973
-
Perspectives in the treatment of vascular dementia
-
Roman G. Perspectives in the treatment of vascular dementia. Drugs Today (Barc). 2000;36:641-653.
-
(2000)
Drugs Today (Barc)
, vol.36
, pp. 641-653
-
-
Roman, G.1
-
212
-
-
0042913340
-
Does aspirin protect against Alzheimer's dementia? A study in a Swedish population-based sample aged > or =80 years
-
Nilsson SE, Johansson B, Takkinen S, et al. Does aspirin protect against Alzheimer's dementia? A study in a Swedish population-based sample aged > or =80 years. Eur J Clin Pharmacol. 2003;59:313-319.
-
(2003)
Eur J Clin Pharmacol
, vol.59
, pp. 313-319
-
-
Nilsson, S.E.1
Johansson, B.2
Takkinen, S.3
-
213
-
-
33646708039
-
Shortened onset of action of antidepressants in major depression using acetylsalicylic acid augmentation: A pilot open-label study
-
Mendlewicz J, Kriwin P, Oswald P, Souery D, Alboni S, Brunello N. Shortened onset of action of antidepressants in major depression using acetylsalicylic acid augmentation: a pilot open-label study. Int Clin Psychopharmacol. 2006;21:227-231.
-
(2006)
Int Clin Psychopharmacol
, vol.21
, pp. 227-231
-
-
Mendlewicz, J.1
Kriwin, P.2
Oswald, P.3
Souery, D.4
Alboni, S.5
Brunello, N.6
-
214
-
-
0018426331
-
Complications of disopyramide therapy
-
Nies AS, Gal J, Gerber JG. Complications of disopyramide therapy. Lancet. 1979;1:330-331.
-
(1979)
Lancet
, vol.1
, pp. 330-331
-
-
Nies, A.S.1
Gal, J.2
Gerber, J.G.3
-
216
-
-
0018693023
-
Disopyramide-induced acute psychosis
-
Ahmad S, Sheikh AI, Meeran MK. Disopyramide-induced acute psychosis. Chest. 1979;76:712.
-
(1979)
Chest
, vol.76
, pp. 712
-
-
Ahmad, S.1
Sheikh, A.I.2
Meeran, M.K.3
-
217
-
-
0029126836
-
The relationship between neurally mediated hypotension and the chronic fatigue syndrome
-
Bou-Holaigah I, Rowe PC, Kan J, Calkins H. The relationship between neurally mediated hypotension and the chronic fatigue syndrome. JAMA. 1995;274:961-967.
-
(1995)
JAMA
, vol.274
, pp. 961-967
-
-
Bou-Holaigah, I.1
Rowe, P.C.2
Kan, J.3
Calkins, H.4
-
218
-
-
0028957255
-
Is neurally mediated hypotension an unrecognised cause of chronic fatigue?
-
Rowe PC, Bou-Holaigah I, Kan JS, Calkins H. Is neurally mediated hypotension an unrecognised cause of chronic fatigue? Lancet. 1995;345:623-624.
-
(1995)
Lancet
, vol.345
, pp. 623-624
-
-
Rowe, P.C.1
Bou-Holaigah, I.2
Kan, J.S.3
Calkins, H.4
-
220
-
-
0027758084
-
Procainamide-induced psychosis
-
Review
-
Harrington L. Procainamide-induced psychosis. Crit Care Nurse. 1993;13:70-72. Review.
-
(1993)
Crit Care Nurse
, vol.13
, pp. 70-72
-
-
Harrington, L.1
-
221
-
-
0021764617
-
Psychosis induced by sustained-release procainamide
-
Schubert DS, Gabinet L, Hershey LA. Psychosis induced by sustained-release procainamide. Can Med Assoc J. 1984;131:1188-1190.
-
(1984)
Can Med Assoc J
, vol.131
, pp. 1188-1190
-
-
Schubert, D.S.1
Gabinet, L.2
Hershey, L.A.3
-
222
-
-
0018410419
-
Procainamide-induced psychosis
-
Menken M. Procainamide-induced psychosis. JAMA. 1979;241:1107-1108.
-
(1979)
JAMA
, vol.241
, pp. 1107-1108
-
-
Menken, M.1
-
223
-
-
0018119893
-
Procainamide-induced psychosis
-
McCrum ID, Guidry JR. Procainamide-induced psychosis. JAMA. 1978;240:1265-1266.
-
(1978)
JAMA
, vol.240
, pp. 1265-1266
-
-
McCrum, I.D.1
Guidry, J.R.2
-
224
-
-
0020032206
-
Pharmacokinetics of a sustained release procainamide preparation
-
Flanagan AD. Pharmacokinetics of a sustained release procainamide preparation. Angiology. 1982;33:71-77.
-
(1982)
Angiology
, vol.33
, pp. 71-77
-
-
Flanagan, A.D.1
-
226
-
-
17644414511
-
Drug-induced lupus
-
Rubin RL. Drug-induced lupus. Toxicology. 2005;209:135-147.
-
(2005)
Toxicology
, vol.209
, pp. 135-147
-
-
Rubin, R.L.1
-
227
-
-
0017528160
-
-
Cohen IS, Jick H, Cohen S1. Adverse reactions to quinidine in hospitalized patients: findings based on data from the Boston Collaborative Drug Surveillance Program. Prog Cardiovasc Dis. 1977;20:151-163.
-
Cohen IS, Jick H, Cohen S1. Adverse reactions to quinidine in hospitalized patients: findings based on data from the Boston Collaborative Drug Surveillance Program. Prog Cardiovasc Dis. 1977;20:151-163.
-
-
-
-
228
-
-
0026683154
-
Cinchonism: Two case reports and review of acute quinine toxicity and treatment
-
Wolf LR, Otten EJ, Spadafora MP. Cinchonism: two case reports and review of acute quinine toxicity and treatment. J Emerg Med. 1992;10:295-301.
-
(1992)
J Emerg Med
, vol.10
, pp. 295-301
-
-
Wolf, L.R.1
Otten, E.J.2
Spadafora, M.P.3
-
229
-
-
0023658814
-
Acute psychosis as idiosyncratic reaction to quinidine: Report of two cases
-
Deleu D, Schmedding E. Acute psychosis as idiosyncratic reaction to quinidine: report of two cases. BMJ (Clin Res Ed). 1987;294:1001-1002.
-
(1987)
BMJ (Clin Res Ed)
, vol.294
, pp. 1001-1002
-
-
Deleu, D.1
Schmedding, E.2
-
230
-
-
0025312537
-
A functional psychosis precipitated by quinidine
-
Johnson AG, Day RO, Seldon WA. A functional psychosis precipitated by quinidine. Med J Aust. 1990;153:47-49.
-
(1990)
Med J Aust
, vol.153
, pp. 47-49
-
-
Johnson, A.G.1
Day, R.O.2
Seldon, W.A.3
-
231
-
-
0017821295
-
Quinidine dementia
-
Gilbert GJ. Quinidine dementia. Am J Cardiol. 1978;41:791.
-
(1978)
Am J Cardiol
, vol.41
, pp. 791
-
-
Gilbert, G.J.1
-
232
-
-
0017756306
-
Quinidine dementia
-
Gilbert GJ. Quinidine dementia. JAMA. 1977;237:2093-2094.
-
(1977)
JAMA
, vol.237
, pp. 2093-2094
-
-
Gilbert, G.J.1
-
233
-
-
0021868657
-
Quinidine-induced organic mental disorders
-
Billig N, Buongiorno P. Quinidine-induced organic mental disorders. J Am Geriatr Soc. 1985;33:504-506.
-
(1985)
J Am Geriatr Soc
, vol.33
, pp. 504-506
-
-
Billig, N.1
Buongiorno, P.2
-
234
-
-
0019845155
-
Neuropsychiatric sequelae of pharmacotherapy of cardiac arrhythmias and hypertension
-
Lloyd BL, Greenblatt DJ. Neuropsychiatric sequelae of pharmacotherapy of cardiac arrhythmias and hypertension. J Clin Psychopharmacol. 1981;1:394-398.
-
(1981)
J Clin Psychopharmacol
, vol.1
, pp. 394-398
-
-
Lloyd, B.L.1
Greenblatt, D.J.2
-
236
-
-
0030887422
-
Paranoid psychosis due to flecainide toxicity in malignant neuropathic pain
-
Bennett MI. Paranoid psychosis due to flecainide toxicity in malignant neuropathic pain. Pain. 1997;70:93-94.
-
(1997)
Pain
, vol.70
, pp. 93-94
-
-
Bennett, M.I.1
-
237
-
-
0022627113
-
Dysarthria and visual hallucinations due to flecainide toxicity
-
Ramhamadany E, Mackenzie S, Ramsdale DR. Dysarthria and visual hallucinations due to flecainide toxicity. Postgrad Med J. 1986;62:61-62.
-
(1986)
Postgrad Med J
, vol.62
, pp. 61-62
-
-
Ramhamadany, E.1
Mackenzie, S.2
Ramsdale, D.R.3
-
238
-
-
0023836704
-
Central nervous system side effects due to anti-arrhythmia therapy. Psychotic depression due to flecainide [in German]
-
Drerup U. Central nervous system side effects due to anti-arrhythmia therapy. Psychotic depression due to flecainide [in German]. Dtsch Med Wochenschr. 1988;113:386-388.
-
(1988)
Dtsch Med Wochenschr
, vol.113
, pp. 386-388
-
-
Drerup, U.1
-
240
-
-
0031734790
-
The thyroid axis and depression
-
Jackson IM. The thyroid axis and depression. Thyroid. 1998;8:951-956.
-
(1998)
Thyroid
, vol.8
, pp. 951-956
-
-
Jackson, I.M.1
-
241
-
-
0034084379
-
Psychoses associated with thyrotoxicosis - "thyrotoxic psychosis." A report of 18 cases, with statistical analysis of incidence
-
Brownlie BE, Rae AM, Walshe JW, Wells JE. Psychoses associated with thyrotoxicosis - "thyrotoxic psychosis." A report of 18 cases, with statistical analysis of incidence. Eur J Endocrinol. 2000;142:438-444.
-
(2000)
Eur J Endocrinol
, vol.142
, pp. 438-444
-
-
Brownlie, B.E.1
Rae, A.M.2
Walshe, J.W.3
Wells, J.E.4
-
245
-
-
0022595599
-
High incidence of clinical and subclinical toxicity associated with amiodarone treatment of refractory tachyarrhythmias
-
Anastasiou-Nana MI, Anderson JL, Nanas JN, et al. High incidence of clinical and subclinical toxicity associated with amiodarone treatment of refractory tachyarrhythmias. Can J Cardiol. 1986;2:138-145.
-
(1986)
Can J Cardiol
, vol.2
, pp. 138-145
-
-
Anastasiou-Nana, M.I.1
Anderson, J.L.2
Nanas, J.N.3
-
246
-
-
0032739882
-
More on amiodarone-induced depression
-
Odelola AT. More on amiodarone-induced depression. Br J Psychiatry. 1999;175:590-591.
-
(1999)
Br J Psychiatry
, vol.175
, pp. 590-591
-
-
Odelola, A.T.1
-
247
-
-
0032944571
-
Amiodarone-induced depression
-
Ambrose A, Salib E. Amiodarone-induced depression. Br J Psychiatry. 1999;174:366-367.
-
(1999)
Br J Psychiatry
, vol.174
, pp. 366-367
-
-
Ambrose, A.1
Salib, E.2
-
248
-
-
0031784747
-
Optimal management of amiodarone therapy: Efficacy and side effects
-
Hilleman D, Miller MA, Parker R, Doering P, Pieper JA. Optimal management of amiodarone therapy: efficacy and side effects. Pharmacotherapy. 1998;18:138S-145S.
-
(1998)
Pharmacotherapy
, vol.18
-
-
Hilleman, D.1
Miller, M.A.2
Parker, R.3
Doering, P.4
Pieper, J.A.5
-
249
-
-
0028318526
-
Neuropsychiatric adverse drug reactions: Passive reports to Health and Welfare Canada's adverse drug reaction database (1965-present)
-
Patten SB, Love EJ. Neuropsychiatric adverse drug reactions: passive reports to Health and Welfare Canada's adverse drug reaction database (1965-present). Int J Psychiatry Med. 1994;24:45-62.
-
(1994)
Int J Psychiatry Med
, vol.24
, pp. 45-62
-
-
Patten, S.B.1
Love, E.J.2
-
250
-
-
34247222780
-
-
Lanoxin (digoxin) prescribing information. Research Triangle Park, NC: GlaxoSmithKline; 2005.
-
Lanoxin (digoxin) prescribing information. Research Triangle Park, NC: GlaxoSmithKline; 2005.
-
-
-
-
251
-
-
0026246158
-
Acute psychoses caused by digitalis poisoning [in Croatian]
-
Durakovic Z, Vucelic B, Plavsic F. Acute psychoses caused by digitalis poisoning [in Croatian]. Lijec Vjesn. 1991;113:417-419.
-
(1991)
Lijec Vjesn
, vol.113
, pp. 417-419
-
-
Durakovic, Z.1
Vucelic, B.2
Plavsic, F.3
-
252
-
-
0021885641
-
Digoxin toxicity presenting with psychosis in a patient with chronic phobic anxiety
-
Carney MW, Rapp S, Pearce K. Digoxin toxicity presenting with psychosis in a patient with chronic phobic anxiety. Clin Neuropharmacol. 1985;8:193-195.
-
(1985)
Clin Neuropharmacol
, vol.8
, pp. 193-195
-
-
Carney, M.W.1
Rapp, S.2
Pearce, K.3
-
253
-
-
0017666512
-
Psychosis: A rare manifestation of digoxin intoxication
-
Singh RB, Singh VP, Somani PN. Psychosis: a rare manifestation of digoxin intoxication. J Indian Med Assoc. 1977;69:62-63.
-
(1977)
J Indian Med Assoc
, vol.69
, pp. 62-63
-
-
Singh, R.B.1
Singh, V.P.2
Somani, P.N.3
-
254
-
-
0016733190
-
Psychosis - a feature of digitalis intoxication
-
Gupta OP, Singh S, Gupta HM. Psychosis - a feature of digitalis intoxication. Indian Heart J. 1975;27:69-70.
-
(1975)
Indian Heart J
, vol.27
, pp. 69-70
-
-
Gupta, O.P.1
Singh, S.2
Gupta, H.M.3
-
255
-
-
0022627192
-
Digitalis intoxication misdiagnosed as depression by primary care physicians
-
Wamboldt FS, Jefferson JW, Wamboldt MZ. Digitalis intoxication misdiagnosed as depression by primary care physicians. Am J Psychiatry. 1986;143:219-221.
-
(1986)
Am J Psychiatry
, vol.143
, pp. 219-221
-
-
Wamboldt, F.S.1
Jefferson, J.W.2
Wamboldt, M.Z.3
-
258
-
-
0035097378
-
Medication use and major depressive syndrome in a community population
-
Patten SB, Lavorato DH. Medication use and major depressive syndrome in a community population. Compr Psychiatry. 2001;42:124-131.
-
(2001)
Compr Psychiatry
, vol.42
, pp. 124-131
-
-
Patten, S.B.1
Lavorato, D.H.2
-
259
-
-
0029824487
-
Case-control studies of cardiovascular medications as risk factors for clinically diagnosed depressive disorders in a hospitalized population
-
Patten SB, Williams JV, Love EJ. Case-control studies of cardiovascular medications as risk factors for clinically diagnosed depressive disorders in a hospitalized population. Can J Psychiatry. 1996;41:469-476.
-
(1996)
Can J Psychiatry
, vol.41
, pp. 469-476
-
-
Patten, S.B.1
Williams, J.V.2
Love, E.J.3
-
260
-
-
34247243411
-
Depressive and anxiety reactions treated with nicotinic acid and phenobarbital
-
Thompson LJ, Proctor RC. Depressive and anxiety reactions treated with nicotinic acid and phenobarbital. N C Med J. 1953;14:420-426.
-
(1953)
N C Med J
, vol.14
, pp. 420-426
-
-
Thompson, L.J.1
Proctor, R.C.2
-
261
-
-
34247206728
-
Nicotinic acid in the treatment of depression
-
Tonge WL. Nicotinic acid in the treatment of depression. Ann Intern Med. 1953;38:551-553.
-
(1953)
Ann Intern Med
, vol.38
, pp. 551-553
-
-
Tonge, W.L.1
-
262
-
-
0012233207
-
Massive niacin treatment in schizophrenia. Review of a nine-year study
-
Osmond H, Hoffer A. Massive niacin treatment in schizophrenia. Review of a nine-year study. Lancet. 1962;1:316-319.
-
(1962)
Lancet
, vol.1
, pp. 316-319
-
-
Osmond, H.1
Hoffer, A.2
-
263
-
-
0345782830
-
Nicotinic acid: An adjunct in the treatment of schizophrenia
-
Hoffer A. Nicotinic acid: an adjunct in the treatment of schizophrenia. Am J Psychiatry. 1963;120:171-173.
-
(1963)
Am J Psychiatry
, vol.120
, pp. 171-173
-
-
Hoffer, A.1
-
264
-
-
0025809410
-
Niacin and vitamin B6 in mental functioning: A review of controlled trials in humans
-
Kleijnen J, Knipschild P. Niacin and vitamin B6 in mental functioning: a review of controlled trials in humans. Biol Psychiatry. 1991;29:931-941.
-
(1991)
Biol Psychiatry
, vol.29
, pp. 931-941
-
-
Kleijnen, J.1
Knipschild, P.2
-
265
-
-
0016295288
-
Negative findings with nicotinic acid in the treatment of schizophrenias
-
Ban TA. Negative findings with nicotinic acid in the treatment of schizophrenias. Int Pharmacopsychiatry. 1974;9:172-187.
-
(1974)
Int Pharmacopsychiatry
, vol.9
, pp. 172-187
-
-
Ban, T.A.1
-
266
-
-
0021511255
-
Cholestyramine induced hyperchloremic metabolic acidosis
-
Eaves ER, Korman MG. Cholestyramine induced hyperchloremic metabolic acidosis. Aust N Z J Med. 1984;14:670-672.
-
(1984)
Aust N Z J Med
, vol.14
, pp. 670-672
-
-
Eaves, E.R.1
Korman, M.G.2
-
267
-
-
0034304746
-
Worldwide Expanded Dose Simvastatin Study Group. Lipid-altering efficacy and safety of simvastatin 80 mg/day: Worldwide long-term experience in patients with hypercholesterolemia
-
Davidson MH, Stein EA, Hunninghake DB, et al. Worldwide Expanded Dose Simvastatin Study Group. Lipid-altering efficacy and safety of simvastatin 80 mg/day: worldwide long-term experience in patients with hypercholesterolemia. Nutr Metab Cardiovasc Dis. 2000;10:253-2562.
-
(2000)
Nutr Metab Cardiovasc Dis
, vol.10
, pp. 253-2562
-
-
Davidson, M.H.1
Stein, E.A.2
Hunninghake, D.B.3
-
268
-
-
0034985133
-
STATT: A titrate-to-goal study of simvastatin in Asian patients with coronary heart disease. Simvastatin Treats Asians to Target
-
Chung N, Cho SY, Choi DH, et al. STATT: a titrate-to-goal study of simvastatin in Asian patients with coronary heart disease. Simvastatin Treats Asians to Target. Clin Ther. 2001;23:858-870.
-
(2001)
Clin Ther
, vol.23
, pp. 858-870
-
-
Chung, N.1
Cho, S.Y.2
Choi, D.H.3
-
269
-
-
0031580631
-
Statins-the pattern of adverse effects with empahsis on mental reactions. Data from a national and an international database [in Norwegian]
-
Buajordet I, Madsen S, Olsen H. Statins-the pattern of adverse effects with empahsis on mental reactions. Data from a national and an international database [in Norwegian], Tidsskr Nor Laegeforen .1997;117:3210-3213.
-
(1997)
Tidsskr Nor Laegeforen
, vol.117
, pp. 3210-3213
-
-
Buajordet, I.1
Madsen, S.2
Olsen, H.3
-
270
-
-
0036167439
-
Cholesterol, essential fatty acids, and suicide
-
Brunner J, Parhofer KG, Schwandt P, Bronisch T. Cholesterol, essential fatty acids, and suicide. Pharmacopsychiatry. 2002;35:1-5.
-
(2002)
Pharmacopsychiatry
, vol.35
, pp. 1-5
-
-
Brunner, J.1
Parhofer, K.G.2
Schwandt, P.3
Bronisch, T.4
-
271
-
-
0028953443
-
Low serum cholesterol level and attempted suicide
-
Golier JA, Marzuk PM, Leon AC, Weiner C, Tardiff K. Low serum cholesterol level and attempted suicide. Am J Psychiatry. 1995;152:419-423.
-
(1995)
Am J Psychiatry
, vol.152
, pp. 419-423
-
-
Golier, J.A.1
Marzuk, P.M.2
Leon, A.C.3
Weiner, C.4
Tardiff, K.5
-
272
-
-
0027935828
-
Total cholesterol and suicidality in depression
-
Sullivan PF, Joyce PR, Bulik CM, Mulder RT, Oakley-Browne M. Total cholesterol and suicidality in depression. Biol Psychiatry. 1994;36:472-477.
-
(1994)
Biol Psychiatry
, vol.36
, pp. 472-477
-
-
Sullivan, P.F.1
Joyce, P.R.2
Bulik, C.M.3
Mulder, R.T.4
Oakley-Browne, M.5
-
273
-
-
0026681128
-
Serum cholesterol level and mortality findings for men screened in the Multiple Risk Factor Intervention Trial. Multiple Risk Factor Intervention Trial Research Group
-
Neaton JD, Blackburn H, Jacobs D, et al. Serum cholesterol level and mortality findings for men screened in the Multiple Risk Factor Intervention Trial. Multiple Risk Factor Intervention Trial Research Group. Arch Intern Med. 1992;152:1490-1500.
-
(1992)
Arch Intern Med
, vol.152
, pp. 1490-1500
-
-
Neaton, J.D.1
Blackburn, H.2
Jacobs, D.3
-
274
-
-
0034127867
-
Grobbee. Higher prevalence of depressive symptoms in middle-aged men with low serum cholesterol levels
-
Steegmans PH, Hoes AW, Bak AA, van der Does E, Grobbee. Higher prevalence of depressive symptoms in middle-aged men with low serum cholesterol levels. Psychosom Med. 2000;62:205-211.
-
(2000)
Psychosom Med
, vol.62
, pp. 205-211
-
-
Steegmans, P.H.1
Hoes, A.W.2
Bak, A.A.3
van der Does, E.4
-
275
-
-
14644404915
-
Cholesterol-lowering therapy evokes time-limited changes in serotonergic transmission
-
Vevera J, Fisar Z, Kvasnicka T, et al. Cholesterol-lowering therapy evokes time-limited changes in serotonergic transmission. Psychiatry Res. 2005;133:197-203.
-
(2005)
Psychiatry Res
, vol.133
, pp. 197-203
-
-
Vevera, J.1
Fisar, Z.2
Kvasnicka, T.3
-
276
-
-
0042835785
-
Lipid-lowering drugs and the risk of depression and suicidal behavior
-
Yang CC, Jick SS, Jick H. Lipid-lowering drugs and the risk of depression and suicidal behavior. Arch Intern Med. 2003;163:1926-1932.
-
(2003)
Arch Intern Med
, vol.163
, pp. 1926-1932
-
-
Yang, C.C.1
Jick, S.S.2
Jick, H.3
-
277
-
-
0042230978
-
Long-term statin use and psychological well-being
-
Young-Xu Y, Chan KA, Liao JK, Ravid S, Blatt CM. Long-term statin use and psychological well-being. J Am Coll Cardiol. 2003;42:690-697.
-
(2003)
J Am Coll Cardiol
, vol.42
, pp. 690-697
-
-
Young-Xu, Y.1
Chan, K.A.2
Liao, J.K.3
Ravid, S.4
Blatt, C.M.5
-
278
-
-
0034645450
-
Long-term assessment of psychological well-being in a randomized placebo-controlled trial of cholesterol reduction with pravastatin. The LIPID Study Investigators
-
Stewart RA, Sharpies KJ, North FM, Menkes DB, Baker J, Simes J. Long-term assessment of psychological well-being in a randomized placebo-controlled trial of cholesterol reduction with pravastatin. The LIPID Study Investigators. Arch Intern Med. 2000;160:3144-3152.
-
(2000)
Arch Intern Med
, vol.160
, pp. 3144-3152
-
-
Stewart, R.A.1
Sharpies, K.J.2
North, F.M.3
Menkes, D.B.4
Baker, J.5
Simes, J.6
-
279
-
-
0028181727
-
Assessing possible hazards of reducing serum cholesterol
-
Law MR, Thompson SG, Wald NJ. Assessing possible hazards of reducing serum cholesterol. BMJ. 1994;308:373-379.
-
(1994)
BMJ
, vol.308
, pp. 373-379
-
-
Law, M.R.1
Thompson, S.G.2
Wald, N.J.3
-
281
-
-
0026630353
-
Depressive symptoms in hypercholesterolaemic patients treated with pravastatin
-
Lechleitner M, Hoppichler F, Konwalinka G, Patsch JR, Braunsteiner H. Depressive symptoms in hypercholesterolaemic patients treated with pravastatin. Lancet. 1992;340:910.
-
(1992)
Lancet
, vol.340
, pp. 910
-
-
Lechleitner, M.1
Hoppichler, F.2
Konwalinka, G.3
Patsch, J.R.4
Braunsteiner, H.5
-
282
-
-
0027514711
-
Depressive symptoms and cholesterol-lowering drugs
-
Duits N, Bos FM. Depressive symptoms and cholesterol-lowering drugs. Lancet. 1993;341:114.
-
(1993)
Lancet
, vol.341
, pp. 114
-
-
Duits, N.1
Bos, F.M.2
-
283
-
-
0034015649
-
Effects of lovastatin on cognitive function and psychological well-being
-
Muldoon MF, Barger SD, Ryan CM, et al. Effects of lovastatin on cognitive function and psychological well-being. Am J Med. 2000;108:538-546.
-
(2000)
Am J Med
, vol.108
, pp. 538-546
-
-
Muldoon, M.F.1
Barger, S.D.2
Ryan, C.M.3
-
284
-
-
0028603352
-
Central nervous system effects of HMG CoA reductase inhibitors: Lovastatin and pravastatin on sleep and cognitive performance in patients with hypercholesterolemia
-
Kostis JB, Rosen RC, Wilson AC. Central nervous system effects of HMG CoA reductase inhibitors: lovastatin and pravastatin on sleep and cognitive performance in patients with hypercholesterolemia. J Clin Pharmacol. 1994;34:989-996.
-
(1994)
J Clin Pharmacol
, vol.34
, pp. 989-996
-
-
Kostis, J.B.1
Rosen, R.C.2
Wilson, A.C.3
-
285
-
-
0036121232
-
Statins inhibit A beta-neurotoxicity in vitro and A beta-induced vasoconstriction and inflammation in rat aortae
-
Paris D, Townsend KP, Humphrey J, Obregon DF, Yokota K, Mullan M. Statins inhibit A beta-neurotoxicity in vitro and A beta-induced vasoconstriction and inflammation in rat aortae. Atherosclerosis. 2002;161:293-239.
-
(2002)
Atherosclerosis
, vol.161
, pp. 293-239
-
-
Paris, D.1
Townsend, K.P.2
Humphrey, J.3
Obregon, D.F.4
Yokota, K.5
Mullan, M.6
-
286
-
-
20844440894
-
Atorvastatin for the treatment of mild to moderate Alzheimer disease: Preliminary results
-
Sparks DL, Sabbagh MN, Connor DJ, et al. Atorvastatin for the treatment of mild to moderate Alzheimer disease: preliminary results. Arch Neurol. 2005;62:753-757.
-
(2005)
Arch Neurol
, vol.62
, pp. 753-757
-
-
Sparks, D.L.1
Sabbagh, M.N.2
Connor, D.J.3
-
287
-
-
0034638746
-
Statins and the risk of dementia
-
Jick H, Zornberg GL, Jick SS, Seshadri S, Drachman DA . Statins and the risk of dementia. Lancet. 2000;356:1627-1631.
-
(2000)
Lancet
, vol.356
, pp. 1627-1631
-
-
Jick, H.1
Zornberg, G.L.2
Jick, S.S.3
Seshadri, S.4
Drachman, D.A.5
-
288
-
-
22844431778
-
Statin use and the risk of incident dementia: The Cardiovascular Health Study
-
Rea TD, Breitner JC, Psaty BM, et al. Statin use and the risk of incident dementia: the Cardiovascular Health Study. Arch Neurol. 2005;62:1047-1051.
-
(2005)
Arch Neurol
, vol.62
, pp. 1047-1051
-
-
Rea, T.D.1
Breitner, J.C.2
Psaty, B.M.3
-
289
-
-
13244295723
-
Do statins reduce risk of incident dementia and Alzheimer disease? The Cache County Study
-
Zandi PP, Sparks DL, Khachaturian AS, et al. Do statins reduce risk of incident dementia and Alzheimer disease? The Cache County Study. Arch Gen Psychiatry. 2005;62:217-224.
-
(2005)
Arch Gen Psychiatry
, vol.62
, pp. 217-224
-
-
Zandi, P.P.1
Sparks, D.L.2
Khachaturian, A.S.3
-
290
-
-
0023811877
-
HMG-CoA reductase inhibitors for hypercholesterolemia
-
Shaefer EJ. HMG-CoA reductase inhibitors for hypercholesterolemia. N Engl J Med. 1988;319:1222-1223.
-
(1988)
N Engl J Med
, vol.319
, pp. 1222-1223
-
-
Shaefer, E.J.1
|